RGD DISEASE ONTOLOGY - ANNOTATIONS
RGD uses the Human Disease Ontology (DO, https://disease-ontology.org/) for disease curation across species. RGD automatically downloads each new release of the ontology on a monthly basis. Some additional terms which are required for RGD's curation purposes but are not currently covered in the official version of DO have been added. As corresponding terms are added to DO, these custom terms are retired and the DO terms substituted in existing annotations and subsequently used for curation.
Term: acute promyelocytic leukemia
Accession: DOID:0060318
browse the term
Definition: An acute myeloid leukemia characterized by accumulation of promyelocytes in the bone marrow and by a translocation between chromosomes 15 and 17. (DO)
Synonyms: exact_synonym: AML M3; APL; M3 ANLL; acute myeloblastic leukaemia type 3; acute myeloblastic leukemia type 3; acute myeloid leukaemia M3; acute myeloid leukemia, M3; acute promyelocytic leukaemia; acute promyelocytic leukemias; progranulocytic leukemia
related_synonym: DNA TOPOISOMERASE II, RESISTANCE TO INHIBITION OF, BY AMSACRINE
primary_id: MESH:D015473
alt_id: MIM:612376
xref: EFO:0000224 ; GARD:538 ; ICD10CM:C92.4 ; NCI:C3182 ; ORDO:520
Please select species to view GViewer data.
Symbol
Object Name
Qualifiers
Evidence
Notes
Source
PubMed Reference(s)
RGD Reference(s)
Position
G
N
Abca1
ATP binding cassette subfamily A member 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:32929351
NCBI chrNW_004624758:6,449,583...6,590,244
Ensembl chrNW_004624758:6,449,629...6,588,664
G
G
ABCA1
ATP binding cassette subfamily A member 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:32929351
NCBI chr12:34,587,123...34,734,936
Ensembl chr12:34,587,118...34,731,642
G
P
ABCA1
ATP binding cassette subfamily A member 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:32929351
NCBI chr 1:246,144,277...246,278,492
Ensembl chr 1:246,144,277...246,278,492
G
S
Abca1
ATP binding cassette subfamily A member 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:32929351
NCBI chrNW_004936559:7,177,887...7,312,660
Ensembl chrNW_004936559:7,177,904...7,312,741
G
D
ABCA1
ATP binding cassette subfamily A member 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:32929351
NCBI chr11:60,761,669...60,869,753
Ensembl chr11:60,761,655...60,890,496
G
B
ABCA1
ATP binding cassette subfamily A member 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:32929351
NCBI chr 9:75,948,831...76,096,136
Ensembl chr 9:104,076,516...104,224,188
G
C
Abca1
ATP binding cassette subfamily A member 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:32929351
NCBI chrNW_004955419:21,553,863...21,681,626
Ensembl chrNW_004955419:21,553,835...21,681,619
G
R
Abca1
ATP binding cassette subfamily A member 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:32929351
NCBI chr 5:72,473,676...72,596,563
Ensembl chr 5:67,681,297...67,801,170
G
M
Abca1
ATP-binding cassette, sub-family A member 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:32929351
NCBI chr 4:53,030,789...53,159,988
Ensembl chr 4:53,030,787...53,159,895
G
H
ABCA1
ATP binding cassette subfamily A member 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:32929351
NCBI chr 9:104,781,006...104,928,155
Ensembl chr 9:104,781,006...104,928,155
G
N
Akt1
AKT serine/threonine kinase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12556562
NCBI chrNW_004624734:507,880...525,295
Ensembl chrNW_004624734:509,368...525,295
G
G
AKT1
AKT serine/threonine kinase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12556562
NCBI chr24:82,704,087...82,730,711
Ensembl chr24:82,704,068...82,727,698
G
P
AKT1
AKT serine/threonine kinase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12556562
G
S
Akt1
AKT serine/threonine kinase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12556562
NCBI chrNW_004936621:620,163...639,115
Ensembl chrNW_004936621:620,074...639,093
G
D
AKT1
AKT serine/threonine kinase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12556562
NCBI chr 8:72,317,399...72,335,686
Ensembl chr 8:72,317,869...72,335,193
G
B
AKT1
AKT serine/threonine kinase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12556562
NCBI chr14:85,417,229...85,444,722
Ensembl chr14:105,208,128...105,236,756
G
C
Akt1
AKT serine/threonine kinase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12556562
NCBI chrNW_004955538:3,208,711...3,224,386
Ensembl chrNW_004955538:3,208,710...3,229,904
G
R
Akt1
AKT serine/threonine kinase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12556562
NCBI chr 6:137,534,810...137,555,131
Ensembl chr 6:131,713,720...131,733,921
G
M
Akt1
thymoma viral proto-oncogene 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12556562
NCBI chr12:112,620,260...112,641,266
Ensembl chr12:112,620,255...112,641,318
G
H
AKT1
AKT serine/threonine kinase 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:12556562
NCBI chr14:104,769,349...104,795,748
Ensembl chr14:104,769,349...104,795,759
G
H
AP002490.1
novel transcript
IAGP
ClinVar Annotator: match by term: Acute promyelocytic leukemia
ClinVar
PMID:25741868 PMID:28492532
NCBI chr11:72,014,291...72,020,910
Ensembl chr11:72,014,291...72,020,910
G
N
Aqp9
aquaporin 9
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23563754
NCBI chrNW_004624781:13,650,612...13,691,175
Ensembl chrNW_004624781:13,648,065...13,691,260
G
G
AQP9
aquaporin 9
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23563754
NCBI chr26:25,326,108...25,374,743
Ensembl chr26:25,326,087...25,373,336
G
P
AQP9
aquaporin 9
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23563754
NCBI chr 1:113,798,380...113,848,452
Ensembl chr 1:113,794,040...113,848,683
G
S
Aqp9
aquaporin 9
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23563754
NCBI chrNW_004936471:19,321,366...19,361,227
Ensembl chrNW_004936471:19,321,426...19,362,146
G
D
AQP9
aquaporin 9
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23563754
NCBI chr30:23,223,413...23,271,893
Ensembl chr30:23,225,331...23,269,076
G
B
AQP9
aquaporin 9
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23563754
NCBI chr15:37,107,061...37,154,887
Ensembl chr15:55,418,767...55,466,541
G
C
Aqp9
aquaporin 9
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23563754
NCBI chrNW_004955450:16,253,706...16,346,602
Ensembl chrNW_004955450:16,253,571...16,302,657
G
R
Aqp9
aquaporin 9
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23563754
NCBI chr 8:80,678,027...80,718,273
Ensembl chr 8:71,797,234...71,837,395
G
M
Aqp9
aquaporin 9
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23563754
NCBI chr 9:71,017,941...71,075,170
Ensembl chr 9:71,017,941...71,075,964
G
H
AQP9
aquaporin 9
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:23563754
NCBI chr15:58,138,169...58,185,911
Ensembl chr15:58,138,169...58,185,911
G
N
Asxl1
ASXL transcriptional regulator 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26285909
NCBI chrNW_004624741:188,985...258,065
Ensembl chrNW_004624741:188,745...250,142
G
G
ASXL1
ASXL transcriptional regulator 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26285909
NCBI chr 2:36,735,449...36,810,447
Ensembl chr 2:36,735,830...36,812,387
G
P
ASXL1
ASXL transcriptional regulator 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26285909
NCBI chr17:35,985,978...36,067,122
Ensembl chr17:35,985,535...36,067,119
G
S
Asxl1
ASXL transcriptional regulator 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26285909
NCBI chrNW_004936485:19,218,494...19,297,188
Ensembl chrNW_004936485:19,227,400...19,298,912
G
D
ASXL1
ASXL transcriptional regulator 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26285909
NCBI chr24:21,725,126...21,804,745
Ensembl chr24:21,661,059...21,802,815
G
B
ASXL1
ASXL transcriptional regulator 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26285909
NCBI chr20:28,647,004...28,727,865
Ensembl chr20:29,774,582...29,850,453
G
C
Asxl1
ASXL transcriptional regulator 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26285909
NCBI chrNW_004955422:28,662,392...28,721,896
Ensembl chrNW_004955422:28,664,282...28,721,896
G
R
Asxl1
ASXL transcriptional regulator 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26285909
NCBI chr 3:162,273,828...162,341,742
Ensembl chr 3:141,813,433...141,881,538
G
M
Asxl1
ASXL transcriptional regulator 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26285909
NCBI chr 2:153,187,750...153,245,927
Ensembl chr 2:153,187,749...153,245,927
G
H
ASXL1
ASXL transcriptional regulator 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:26285909
NCBI chr20:32,358,331...32,439,319
Ensembl chr20:32,358,330...32,439,319
G
N
Birc5
baculoviral IAP repeat containing 5
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27770503
NCBI chrNW_004624801:7,727,084...7,735,946
Ensembl chrNW_004624801:7,727,093...7,735,940
G
G
BIRC5
baculoviral IAP repeat containing 5
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27770503
NCBI chr16:70,226,824...70,237,000
G
P
BIRC5
baculoviral IAP repeat containing 5
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27770503
NCBI chr12:3,747,276...3,755,214
Ensembl chr12:3,747,279...3,755,215
G
S
Birc5
baculoviral IAP repeat containing 5
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27770503
NCBI chrNW_004936594:2,812,165...2,820,618
Ensembl chrNW_004936594:2,812,238...2,820,636
G
D
BIRC5
baculoviral IAP repeat containing 5
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27770503
NCBI chr 9:2,930,308...2,959,307
G
B
BIRC5
baculoviral IAP repeat containing 5
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27770503
NCBI chr17:72,292,332...72,303,493
Ensembl chr17:77,842,724...77,854,159
G
R
Birc5
baculoviral IAP repeat-containing 5
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27770503
NCBI chr10:103,567,369...103,580,069
Ensembl chr10:103,073,408...103,081,380
G
M
Birc5
baculoviral IAP repeat-containing 5
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27770503
NCBI chr11:117,740,063...117,746,569
Ensembl chr11:117,740,077...117,746,569
G
H
BIRC5
baculoviral IAP repeat containing 5
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:27770503
NCBI chr17:78,214,253...78,225,635
Ensembl chr17:78,214,186...78,225,636
G
N
Cd44
CD44 molecule (IN blood group)
ISO
CTD Direct Evidence: marker/mechanism|therapeutic
CTD
PMID:16208414 PMID:17349212
NCBI chrNW_004624767:11,938,452...12,024,970
Ensembl chrNW_004624767:11,938,028...12,025,069
G
G
CD44
CD44 molecule (IN blood group)
ISO
CTD Direct Evidence: marker/mechanism|therapeutic
CTD
PMID:16208414 PMID:17349212
NCBI chr 1:30,039,854...30,132,646
Ensembl chr 1:30,039,749...30,132,416
G
P
CD44
CD44 molecule
ISO
CTD Direct Evidence: marker/mechanism|therapeutic
CTD
PMID:16208414 PMID:17349212
NCBI chr 2:25,788,699...25,884,209
Ensembl chr 2:25,788,703...25,884,153
G
S
Cd44
CD44 molecule (IN blood group)
ISO
CTD Direct Evidence: marker/mechanism|therapeutic
CTD
PMID:16208414 PMID:17349212
NCBI chrNW_004936533:2,949,026...3,033,166
G
D
CD44
CD44 molecule
ISO
CTD Direct Evidence: marker/mechanism|therapeutic
CTD
PMID:16208414 PMID:17349212
NCBI chr18:32,735,493...32,826,483
Ensembl chr18:32,737,907...32,827,107
G
B
CD44
CD44 molecule (IN blood group)
ISO
CTD Direct Evidence: marker/mechanism|therapeutic
CTD
PMID:16208414 PMID:17349212
NCBI chr11:35,110,732...35,258,238
Ensembl chr11:34,985,634...35,079,009
G
C
Cd44
CD44 molecule (IN blood group)
ISO
CTD Direct Evidence: marker/mechanism|therapeutic
CTD
PMID:16208414 PMID:17349212
NCBI chrNW_004955422:11,106,061...11,189,951
G
R
Cd44
CD44 molecule
ISO
CTD Direct Evidence: marker/mechanism|therapeutic
CTD
PMID:16208414 PMID:17349212
NCBI chr 3:109,610,824...109,699,776
Ensembl chr 3:89,157,058...89,244,620
G
M
Cd44
CD44 antigen
ISO
CTD Direct Evidence: marker/mechanism|therapeutic
CTD
PMID:16208414 PMID:17349212
NCBI chr 2:102,641,486...102,732,014
Ensembl chr 2:102,641,486...102,732,010
G
H
CD44
CD44 molecule (IN blood group)
EXP
CTD Direct Evidence: marker/mechanism|therapeutic
CTD
PMID:16208414 PMID:17349212
NCBI chr11:35,139,171...35,232,402
Ensembl chr11:35,138,882...35,232,402
G
N
Cdkn2b
cyclin dependent kinase inhibitor 2B
disease_progression
ISO
DNA:hyprmethylation:promoter:
RGD
PMID:12750706
RGD:11252187
NCBI chrNW_004624736:25,929,314...25,933,318
Ensembl chrNW_004624736:25,926,668...25,933,440
G
P
CDKN2B
cyclin dependent kinase inhibitor 2B
disease_progression
ISO
DNA:hyprmethylation:promoter:
RGD
PMID:12750706
RGD:11252187
NCBI chr 1:200,666,250...200,770,880
Ensembl chr 1:200,761,004...200,766,056
G
S
Cdkn2b
cyclin dependent kinase inhibitor 2B
disease_progression
ISO
DNA:hyprmethylation:promoter:
RGD
PMID:12750706
RGD:11252187
NCBI chrNW_004936652:3,576,975...3,582,790
Ensembl chrNW_004936652:3,538,986...3,581,159
G
D
CDKN2B
cyclin dependent kinase inhibitor 2B
disease_progression
ISO
DNA:hyprmethylation:promoter:
RGD
PMID:12750706
RGD:11252187
NCBI chr11:41,259,627...41,264,832
G
B
CDKN2B
cyclin dependent kinase inhibitor 2B
disease_progression
ISO
DNA:hyprmethylation:promoter:
RGD
PMID:12750706
RGD:11252187
NCBI chr 9:21,838,902...21,845,355
Ensembl chr 9:22,455,662...22,462,156
G
C
Cdkn2b
cyclin dependent kinase inhibitor 2B
disease_progression
ISO
DNA:hyprmethylation:promoter:
RGD
PMID:12750706
RGD:11252187
NCBI chrNW_004955472:12,275,613...12,280,141
Ensembl chrNW_004955472:12,275,544...12,280,528
G
R
Cdkn2b
cyclin-dependent kinase inhibitor 2B
disease_progression
ISO
DNA:hyprmethylation:promoter:
RGD
PMID:12750706
RGD:11252187
NCBI chr 5:109,123,308...109,134,906
Ensembl chr 5:104,010,680...104,019,050
G
M
Cdkn2b
cyclin dependent kinase inhibitor 2B
disease_progression
ISO
DNA:hyprmethylation:promoter:
RGD
PMID:12750706
RGD:11252187
NCBI chr 4:89,224,526...89,229,269
Ensembl chr 4:89,224,536...89,229,276
G
H
CDKN2B
cyclin dependent kinase inhibitor 2B
disease_progression
IDA
DNA:hyprmethylation:promoter:
RGD
PMID:12750706
RGD:11252187
NCBI chr 9:22,002,903...22,009,313
Ensembl chr 9:22,002,903...22,009,305
G
N
Cebpa
CCAAT enhancer binding protein alpha
ISO
CTD Direct Evidence: marker/mechanism|therapeutic
CTD
PMID:16788101 PMID:26285909
NCBI chrNW_004624794:9,809,007...9,813,418
G
G
CEBPA
CCAAT enhancer binding protein alpha
ISO
CTD Direct Evidence: marker/mechanism|therapeutic
CTD
PMID:16788101 PMID:26285909
NCBI chr 6:28,342,506...28,345,759
Ensembl chr 6:28,343,907...28,344,977
G
P
CEBPA
CCAAT enhancer binding protein alpha
ISO
CTD Direct Evidence: marker/mechanism|therapeutic
CTD
PMID:16788101 PMID:26285909
NCBI chr 6:43,083,200...43,085,884
Ensembl chr 6:43,083,207...43,085,836
G
S
Cebpa
CCAAT enhancer binding protein alpha
ISO
CTD Direct Evidence: marker/mechanism|therapeutic
CTD
PMID:16788101 PMID:26285909
NCBI chrNW_004936570:2,513,561...2,516,213
G
D
CEBPA
CCAAT enhancer binding protein alpha
ISO
CTD Direct Evidence: marker/mechanism|therapeutic
CTD
PMID:16788101 PMID:26285909
NCBI chr 1:118,846,252...118,851,045
G
B
CEBPA
CCAAT enhancer binding protein alpha
ISO
CTD Direct Evidence: marker/mechanism|therapeutic
CTD
PMID:16788101 PMID:26285909
NCBI chr19:30,223,567...30,226,204
G
C
Cebpa
CCAAT enhancer binding protein alpha
ISO
CTD Direct Evidence: marker/mechanism|therapeutic
CTD
PMID:16788101 PMID:26285909
NCBI chrNW_004955468:3,046,544...3,049,217
Ensembl chrNW_004955468:3,047,931...3,049,080
G
R
Cebpa
CCAAT/enhancer binding protein alpha
ISO
CTD Direct Evidence: marker/mechanism|therapeutic
CTD
PMID:16788101 PMID:26285909
NCBI chr 1:96,896,584...96,899,256
Ensembl chr 1:87,759,433...87,762,412
G
M
Cebpa
CCAAT/enhancer binding protein alpha
ISO
CTD Direct Evidence: marker/mechanism|therapeutic
CTD
PMID:16788101 PMID:26285909
NCBI chr 7:34,818,718...34,821,353
Ensembl chr 7:34,818,718...34,821,353
G
H
CEBPA
CCAAT enhancer binding protein alpha
EXP
CTD Direct Evidence: marker/mechanism|therapeutic
CTD
PMID:16788101 PMID:26285909
NCBI chr19:33,299,934...33,302,534
Ensembl chr19:33,299,934...33,302,534
G
N
Cebpe
CCAAT enhancer binding protein epsilon
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:16788101
NCBI chrNW_004624820:9,423,725...9,425,338
Ensembl chrNW_004624820:9,423,725...9,425,338
G
G
CEBPE
CCAAT enhancer binding protein epsilon
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:16788101
NCBI chr29:23,485,966...23,488,615
Ensembl chr29:23,486,148...23,487,755
G
P
CEBPE
CCAAT enhancer binding protein epsilon
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:16788101
NCBI chr 7:75,926,652...75,929,949
Ensembl chr 7:75,927,662...75,929,769
G
S
Cebpe
CCAAT enhancer binding protein epsilon
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:16788101
NCBI chrNW_004936722:1,207,718...1,209,482
Ensembl chrNW_004936722:1,207,743...1,209,482
G
D
CEBPE
CCAAT enhancer binding protein epsilon
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:16788101
NCBI chr 8:3,423,046...3,425,595
Ensembl chr 8:3,423,040...3,425,217
G
B
CEBPE
CCAAT enhancer binding protein epsilon
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:16788101
NCBI chr14:3,937,200...3,939,112
Ensembl chr14:22,033,654...22,035,219
G
C
Cebpe
CCAAT enhancer binding protein epsilon
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:16788101
NCBI chrNW_004955409:37,186,282...37,187,914
Ensembl chrNW_004955409:37,186,039...37,187,921
G
R
Cebpe
CCAAT/enhancer binding protein epsilon
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:16788101
NCBI chr15:32,139,716...32,141,476
Ensembl chr15:28,169,704...28,171,814
G
M
Cebpe
CCAAT/enhancer binding protein epsilon
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:16788101
NCBI chr14:54,947,823...54,949,604
Ensembl chr14:54,947,817...54,949,631
G
H
CEBPE
CCAAT enhancer binding protein epsilon
EXP
CTD Direct Evidence: therapeutic
CTD
PMID:16788101
NCBI chr14:23,117,306...23,119,255
Ensembl chr14:23,117,036...23,120,256
G
N
Dapk2
death associated protein kinase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28978663
NCBI chrNW_004624781:8,507,508...8,606,931
Ensembl chrNW_004624781:8,513,700...8,617,883
G
G
DAPK2
death associated protein kinase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28978663
NCBI chr26:19,492,112...19,637,453
G
P
DAPK2
death associated protein kinase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28978663
NCBI chr 1:107,997,274...108,131,723
Ensembl chr 1:107,997,293...108,132,781
G
S
Dapk2
death associated protein kinase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28978663
NCBI chrNW_004936471:24,412,035...24,527,007
Ensembl chrNW_004936471:24,412,029...24,527,023
G
D
DAPK2
death associated protein kinase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28978663
NCBI chr30:28,440,616...28,565,089
Ensembl chr30:28,441,161...28,565,566
G
B
DAPK2
death associated protein kinase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28978663
NCBI chr15:42,860,484...42,999,489
Ensembl chr15:61,152,553...61,284,990
G
C
Dapk2
death associated protein kinase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28978663
NCBI chrNW_004955450:11,348,566...11,443,908
Ensembl chrNW_004955450:11,348,566...11,455,582
G
R
Dapk2
death-associated protein kinase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28978663
NCBI chr 8:75,601,621...75,720,619
Ensembl chr 8:66,706,609...66,825,567
G
M
Dapk2
death-associated protein kinase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28978663
NCBI chr 9:66,065,364...66,179,524
Ensembl chr 9:66,065,505...66,179,524
G
H
DAPK2
death associated protein kinase 2
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:28978663
NCBI chr15:63,907,036...64,046,485
Ensembl chr15:63,907,036...64,072,033
G
R
Defa3
defensin alpha 3
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:16019513
NCBI chr16:77,235,885...77,238,041
Ensembl chr16:70,533,436...70,535,604
G
M
Defa3
defensin, alpha, 3
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:16019513
NCBI chr 8:21,777,425...21,778,393
Ensembl chr 8:21,777,425...21,778,393
G
H
DEFA3
defensin alpha 3
EXP
CTD Direct Evidence: therapeutic
CTD
PMID:16019513
NCBI chr 8:7,015,869...7,018,297
Ensembl chr 8:7,015,869...7,018,297
G
N
Dhcr7
7-dehydrocholesterol reductase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:32929351
NCBI chrNW_004624767:16,118,157...16,132,225
Ensembl chrNW_004624767:16,118,052...16,132,834
G
G
DHCR7
7-dehydrocholesterol reductase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:32929351
NCBI chr 1:3,243,263...3,257,332
Ensembl chr 1:3,243,313...3,257,487
G
P
DHCR7
7-dehydrocholesterol reductase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:32929351
NCBI chr 2:2,377,352...2,391,846
Ensembl chr 2:2,377,416...2,391,447
G
D
DHCR7
7-dehydrocholesterol reductase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:32929351
NCBI chr18:47,257,750...47,277,436
Ensembl chr18:47,261,730...47,274,236
G
B
DHCR7
7-dehydrocholesterol reductase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:32929351
NCBI chr11:66,450,230...66,464,214
Ensembl chr11:69,721,741...69,735,715
G
C
Dhcr7
7-dehydrocholesterol reductase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:32929351
NCBI chrNW_004955422:15,119,155...15,136,771
Ensembl chrNW_004955422:15,119,173...15,136,771
G
R
Dhcr7
7-dehydrocholesterol reductase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:32929351
NCBI chr 1:208,444,434...208,460,408
Ensembl chr 1:199,015,081...199,031,055
G
M
Dhcr7
7-dehydrocholesterol reductase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:32929351
NCBI chr 7:143,376,827...143,402,147
Ensembl chr 7:143,376,882...143,402,147
G
H
DHCR7
7-dehydrocholesterol reductase
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:32929351
NCBI chr11:71,427,287...71,449,043
Ensembl chr11:71,428,193...71,452,868
G
N
Dnmt3a
DNA methyltransferase 3 alpha
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26285909
NCBI chrNW_004624738:7,481,084...7,581,332
Ensembl chrNW_004624738:7,485,842...7,581,056
G
G
DNMT3A
DNA methyltransferase 3 alpha
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26285909
NCBI chr14:82,313,414...82,427,170
Ensembl chr14:82,402,826...82,420,819
G
P
DNMT3A
DNA methyltransferase 3 alpha
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26285909
NCBI chr 3:113,501,972...113,609,148
Ensembl chr 3:113,528,926...113,603,087
G
S
Dnmt3a
DNA methyltransferase 3 alpha
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26285909
NCBI chrNW_004936493:6,963,406...7,013,256
Ensembl chrNW_004936493:6,935,386...7,007,610
G
D
DNMT3A
DNA methyltransferase 3 alpha
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26285909
NCBI chr17:19,489,524...19,563,074
Ensembl chr17:19,492,193...19,563,902
G
B
DNMT3A
DNA methyltransferase 3 alpha
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26285909
NCBI chr2A:25,229,593...25,344,733
Ensembl chr2A:25,331,095...25,412,605
G
C
Dnmt3a
DNA methyltransferase 3 alpha
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26285909
NCBI chrNW_004955469:7,264,431...7,367,059
Ensembl chrNW_004955469:7,269,952...7,367,059
G
R
Dnmt3a
DNA methyltransferase 3 alpha
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26285909
NCBI chr 6:32,507,316...32,621,678
Ensembl chr 6:26,822,609...26,896,687
G
M
Dnmt3a
DNA methyltransferase 3A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26285909
NCBI chr12:3,851,559...3,964,442
Ensembl chr12:3,856,007...3,964,443
G
H
DNMT3A
DNA methyltransferase 3 alpha
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:26285909
NCBI chr 2:25,227,874...25,342,590
Ensembl chr 2:25,227,855...25,342,590
G
N
F3
coagulation factor III, tissue factor
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:10726043 PMID:16206674
RGD:11340216
NCBI chrNW_004624742:3,112,827...3,123,424
Ensembl chrNW_004624742:3,112,801...3,124,301
G
G
F3
coagulation factor III, tissue factor
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:10726043 PMID:16206674
RGD:11340216
NCBI chr20:38,726,690...38,738,457
Ensembl chr20:38,726,798...38,739,408
G
P
F3
coagulation factor III, tissue factor
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:10726043 PMID:16206674
RGD:11340216
NCBI chr 4:122,827,018...122,837,673
Ensembl chr 4:122,826,644...122,837,666
G
S
F3
coagulation factor III, tissue factor
ISO
CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:10726043 PMID:16206674
RGD:11340216
NCBI chrNW_004936537:4,637,028...4,647,915
Ensembl chrNW_004936537:4,636,667...4,647,916
G
D
F3
coagulation factor III, tissue factor
ISO
CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:10726043 PMID:16206674
RGD:11340216
NCBI chr 6:54,709,581...54,720,603
Ensembl chr 6:54,708,471...54,720,607
G
B
F3
coagulation factor III, tissue factor
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:10726043 PMID:16206674
RGD:11340216
NCBI chr 1:97,190,381...97,203,076
Ensembl chr 1:95,918,502...95,931,050
G
C
F3
coagulation factor III, tissue factor
ISO
CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:10726043 PMID:16206674
RGD:11340216
NCBI chrNW_004955423:254,060...264,448
Ensembl chrNW_004955423:254,189...264,159
G
R
F3
coagulation factor III, tissue factor
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:16206674 PMID:10726043
RGD:11340216
NCBI chr 2:212,511,675...212,523,375
Ensembl chr 2:209,826,959...209,838,668
G
M
F3
coagulation factor III, tissue factor
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:16206674 PMID:10726043
RGD:11340216
NCBI chr 3:121,517,186...121,528,701
Ensembl chr 3:121,517,186...121,528,697
G
H
F3
coagulation factor III, tissue factor
IEP EXP
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:16206674 PMID:10726043
RGD:11340216
NCBI chr 1:94,529,173...94,541,759
Ensembl chr 1:94,529,173...94,541,759
G
N
Flt3
fms related receptor tyrosine kinase 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17454189 PMID:24160850 PMID:26285909
NCBI chrNW_004624776:10,407,083...10,516,350
Ensembl chrNW_004624776:10,435,850...10,517,066
G
G
FLT3
fms related receptor tyrosine kinase 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17454189 PMID:24160850 PMID:26285909
NCBI chr 3:7,117,579...7,222,600
Ensembl chr 3:7,116,947...7,222,849
G
P
FLT3
fms related receptor tyrosine kinase 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17454189 PMID:24160850 PMID:26285909
NCBI chr11:5,370,475...5,455,439
Ensembl chr11:5,370,496...5,455,358
G
S
Flt3
fms related receptor tyrosine kinase 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17454189 PMID:24160850 PMID:26285909
NCBI chrNW_004936472:23,169,967...23,239,178
Ensembl chrNW_004936472:23,170,470...23,256,904
G
D
FLT3
fms related receptor tyrosine kinase 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17454189 PMID:24160850 PMID:26285909
NCBI chr25:11,551,372...11,670,891
Ensembl chr25:11,581,206...11,692,284
G
B
FLT3
fms related receptor tyrosine kinase 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17454189 PMID:24160850 PMID:26285909
NCBI chr13:9,283,747...9,381,553
Ensembl chr13:27,627,178...27,723,940
G
C
Flt3
fms related receptor tyrosine kinase 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17454189 PMID:24160850 PMID:26285909
NCBI chrNW_004955497:7,357,533...7,441,215
Ensembl chrNW_004955497:7,357,212...7,461,439
G
R
Flt3
Fms related receptor tyrosine kinase 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17454189 PMID:24160850 PMID:26285909
NCBI chr12:12,660,035...12,735,584
Ensembl chr12:7,623,930...7,699,474
G
M
Flt3
FMS-like tyrosine kinase 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17454189 PMID:24160850 PMID:26285909
NCBI chr 5:147,267,551...147,337,299
Ensembl chr 5:147,267,551...147,337,299
G
H
FLT3
fms related receptor tyrosine kinase 3
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:17454189 PMID:24160850 PMID:26285909
NCBI chr13:28,003,274...28,100,576
Ensembl chr13:28,003,274...28,100,592
G
N
Fndc3b
fibronectin type III domain containing 3B
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28314734
NCBI chrNW_004624730:50,111,873...50,447,035
Ensembl chrNW_004624730:50,111,346...50,450,164
G
G
FNDC3B
fibronectin type III domain containing 3B
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28314734
NCBI chr15:17,060,117...17,428,340
Ensembl chr15:17,059,959...17,428,339
G
P
FNDC3B
fibronectin type III domain containing 3B
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28314734
NCBI chr13:110,587,464...110,931,687
Ensembl chr13:110,587,463...110,928,465
G
S
Fndc3b
fibronectin type III domain containing 3B
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28314734
NCBI chrNW_004936593:311,245...638,625
Ensembl chrNW_004936593:311,245...566,800
G
D
FNDC3B
fibronectin type III domain containing 3B
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28314734
NCBI chr34:36,373,966...36,640,851
Ensembl chr34:36,302,386...36,637,583
G
B
FNDC3B
fibronectin type III domain containing 3B
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28314734
NCBI chr 3:169,047,205...169,408,664
Ensembl chr 3:177,301,873...177,590,367
G
C
Fndc3b
fibronectin type III domain containing 3B
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28314734
NCBI chrNW_004955420:2,173,804...2,435,324
Ensembl chrNW_004955420:2,114,663...2,438,491
G
R
Fndc3b
fibronectin type III domain containing 3B
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28314734
NCBI chr 2:112,240,108...112,546,113
Ensembl chr 2:110,312,694...110,547,830
G
M
Fndc3b
fibronectin type III domain containing 3B
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28314734
NCBI chr 3:27,470,284...27,765,469
Ensembl chr 3:27,470,311...27,765,456
G
H
FNDC3B
fibronectin type III domain containing 3B
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:28314734
NCBI chr 3:172,039,578...172,401,669
Ensembl chr 3:172,039,578...172,401,669
G
N
Gli1
GLI family zinc finger 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23867347
NCBI chrNW_004624802:10,483,279...10,494,539
Ensembl chrNW_004624802:10,483,219...10,498,609
G
G
GLI1
GLI family zinc finger 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23867347
NCBI chr11:53,371,929...53,384,339
Ensembl chr11:53,375,558...53,385,269
G
P
GLI1
GLI family zinc finger 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23867347
NCBI chr 5:22,736,325...22,747,421
Ensembl chr 5:22,739,900...22,747,421
G
S
Gli1
GLI family zinc finger 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23867347
NCBI chrNW_004936646:1,622,308...1,629,787
Ensembl chrNW_004936646:1,622,308...1,629,779
G
D
GLI1
GLI family zinc finger 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23867347
NCBI chr10:1,565,306...1,575,971
Ensembl chr10:1,565,244...1,575,982
G
B
GLI1
GLI family zinc finger 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23867347
NCBI chr12:31,453,759...31,466,194
Ensembl chr12:31,710,057...31,722,473
G
C
Gli1
GLI family zinc finger 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23867347
NCBI chrNW_004955458:5,181,761...5,193,500
Ensembl chrNW_004955458:5,185,225...5,193,196
G
R
Gli1
GLI family zinc finger 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23867347
NCBI chr 7:65,042,237...65,054,888
Ensembl chr 7:63,156,926...63,169,251
G
M
Gli1
GLI-Kruppel family member GLI1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23867347
NCBI chr10:127,165,751...127,177,448
Ensembl chr10:127,165,751...127,177,843
G
H
GLI1
GLI family zinc finger 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:23867347
NCBI chr12:57,459,785...57,472,268
Ensembl chr12:57,459,785...57,472,268
G
N
Gli2
GLI family zinc finger 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23867347
NCBI chrNW_004624732:24,159,407...24,381,495
Ensembl chrNW_004624732:24,159,312...24,328,452
G
G
GLI2
GLI family zinc finger 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23867347
NCBI chr10:9,302,890...9,561,287
Ensembl chr10:9,304,645...9,369,115
G
P
GLI2
GLI family zinc finger 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23867347
NCBI chr15:30,312,528...30,580,272
Ensembl chr15:30,313,817...30,579,306
G
S
Gli2
GLI family zinc finger 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23867347
NCBI chrNW_004936469:49,616,552...49,788,760
Ensembl chrNW_004936469:49,617,095...49,673,213
G
D
GLI2
GLI family zinc finger 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23867347
NCBI chr19:29,128,401...29,383,324
Ensembl chr19:29,130,227...29,383,658
G
B
GLI2
GLI family zinc finger 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23867347
NCBI chr2B:7,665,403...7,922,840
Ensembl chr2B:121,303,831...121,497,442
G
C
Gli2
GLI family zinc finger 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23867347
NCBI chrNW_004955459:8,892,917...9,124,672
Ensembl chrNW_004955459:8,892,869...9,118,499
G
R
Gli2
GLI family zinc finger 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23867347
NCBI chr13:32,499,678...32,716,418
Ensembl chr13:29,946,809...30,163,574
G
M
Gli2
GLI-Kruppel family member GLI2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23867347
NCBI chr 1:118,761,791...118,987,578
Ensembl chr 1:118,761,862...118,981,349
G
H
GLI2
GLI family zinc finger 2
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:23867347
NCBI chr 2:120,735,868...120,992,653
Ensembl chr 2:120,735,623...120,992,653
G
N
Gphn
gephyrin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:32929351
NCBI chrNW_004624734:33,871,664...34,483,770
Ensembl chrNW_004624734:33,870,997...34,483,508
G
G
GPHN
gephyrin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:32929351
NCBI chr24:43,702,384...44,421,890
Ensembl chr24:43,880,344...44,422,276
G
P
GPHN
gephyrin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:32929351
NCBI chr 7:90,345,726...90,913,625
Ensembl chr 7:90,346,714...90,916,455
G
S
Gphn
gephyrin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:32929351
NCBI chrNW_004936495:9,970,683...10,565,467
Ensembl chrNW_004936495:9,972,007...10,564,591
G
D
GPHN
gephyrin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:32929351
NCBI chr 8:40,585,625...41,204,007
Ensembl chr 8:40,585,883...41,203,245
G
B
GPHN
gephyrin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:32929351
NCBI chr14:47,081,527...47,755,182
Ensembl chr14:66,137,166...66,634,550
G
C
Gphn
gephyrin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:32929351
NCBI chrNW_004955466:3,017,474...3,526,375
Ensembl chrNW_004955466:3,016,479...3,526,231
G
R
Gphn
gephyrin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:32929351
NCBI chr 6:102,687,405...103,216,679
Ensembl chr 6:96,892,148...97,483,612
G
M
Gphn
gephyrin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:32929351
NCBI chr12:78,264,099...78,731,546
Ensembl chr12:78,273,153...78,731,546
G
H
GPHN
gephyrin
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:32929351
NCBI chr14:66,508,147...67,735,355
Ensembl chr14:66,507,407...67,181,803
G
R
Gstt1
glutathione S-transferase theta 1
susceptibility
ISO
RGD
PMID:21875282
RGD:10755406
NCBI chr20:12,856,068...12,873,020
Ensembl chr20:12,856,669...12,873,585
G
M
Gstt1
glutathione S-transferase, theta 1
susceptibility
ISO
RGD
PMID:21875282
RGD:10755406
NCBI chr10:75,619,647...75,634,418
Ensembl chr10:75,619,647...75,634,418
G
H
GSTT1
glutathione S-transferase theta 1
susceptibility
IAGP
RGD
PMID:21875282
RGD:10755406
G
N
Idh1
isocitrate dehydrogenase (NADP(+)) 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26285909
NCBI chrNW_004624765:7,806,560...7,825,520
G
G
IDH1
isocitrate dehydrogenase (NADP(+)) 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26285909
NCBI chr10:94,021,002...94,039,997
Ensembl chr10:94,020,818...94,039,975
G
P
IDH1
isocitrate dehydrogenase (NADP(+)) 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26285909
NCBI chr15:111,341,153...111,362,330
Ensembl chr15:111,341,153...111,362,296
G
S
Idh1
isocitrate dehydrogenase (NADP(+)) 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26285909
NCBI chrNW_004936950:334,894...349,221
Ensembl chrNW_004936950:334,934...348,363
G
D
IDH1
isocitrate dehydrogenase (NADP(+)) 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26285909
NCBI chr37:16,512,027...16,531,269
Ensembl chr37:16,512,770...16,531,219
G
B
IDH1
isocitrate dehydrogenase (NADP(+)) 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26285909
NCBI chr2B:95,475,320...95,494,286
Ensembl chr2B:213,599,036...213,617,175
G
C
Idh1
isocitrate dehydrogenase (NADP(+)) 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26285909
NCBI chrNW_004955457:6,851,542...6,869,452
Ensembl chrNW_004955457:6,851,517...6,872,367
G
R
Idh1
isocitrate dehydrogenase (NADP(+)) 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26285909
NCBI chr 9:74,027,887...74,057,442
Ensembl chr 9:66,534,146...66,563,708
G
M
Idh1
isocitrate dehydrogenase 1 (NADP+), soluble
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26285909
NCBI chr 1:65,197,775...65,225,638
Ensembl chr 1:65,197,775...65,225,659
G
H
IDH1
isocitrate dehydrogenase (NADP(+)) 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:26285909
NCBI chr 2:208,236,227...208,255,071
Ensembl chr 2:208,236,229...208,266,074
G
N
Idh2
isocitrate dehydrogenase (NADP(+)) 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26285909
NCBI chrNW_004624768:17,094,649...17,111,333
Ensembl chrNW_004624768:17,094,655...17,111,397
G
P
IDH2
isocitrate dehydrogenase (NADP(+)) 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26285909
NCBI chr 7:55,654,298...55,675,571
Ensembl chr 7:55,651,609...55,675,554
G
S
Idh2
isocitrate dehydrogenase (NADP(+)) 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26285909
NCBI chrNW_004936483:15,845,777...15,864,341
Ensembl chrNW_004936483:15,845,792...15,864,341
G
D
IDH2
isocitrate dehydrogenase (NADP(+)) 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26285909
NCBI chr 3:53,070,462...53,077,566
Ensembl chr 3:53,070,695...53,087,496
G
B
IDH2
isocitrate dehydrogenase (NADP(+)) 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26285909
NCBI chr15:68,771,050...68,790,523
Ensembl chr15:87,972,889...87,991,276
G
C
Idh2
isocitrate dehydrogenase (NADP(+)) 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26285909
NCBI chrNW_004955416:15,197,611...15,212,919
Ensembl chrNW_004955416:15,197,366...15,223,363
G
R
Idh2
isocitrate dehydrogenase (NADP(+)) 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26285909
NCBI chr 1:143,447,925...143,467,248
Ensembl chr 1:134,029,772...134,058,025
G
M
Idh2
isocitrate dehydrogenase 2 (NADP+), mitochondrial
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26285909
NCBI chr 7:79,744,594...79,768,356
Ensembl chr 7:79,744,594...79,765,140
G
H
IDH2
isocitrate dehydrogenase (NADP(+)) 2
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:26285909
NCBI chr15:90,083,045...90,102,468
Ensembl chr15:90,083,045...90,102,477
G
N
Ifng
interferon gamma
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22617429
NCBI chrNW_004624802:163,261...166,534
Ensembl chrNW_004624802:163,261...166,534
G
G
IFNG
interferon gamma
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22617429
NCBI chr11:63,785,493...63,791,071
Ensembl chr11:63,786,041...63,790,473
G
P
IFNG
interferon gamma
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22617429
NCBI chr 5:32,477,906...32,482,670
Ensembl chr 5:32,477,906...32,482,670
G
S
Ifng
interferon gamma
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22617429
NCBI chrNW_004936545:6,139,130...6,144,543
Ensembl chrNW_004936545:6,139,116...6,148,452
G
D
IFNG
interferon gamma
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22617429
NCBI chr10:10,406,866...10,411,698
Ensembl chr10:10,406,867...10,411,698
G
B
IFNG
interferon gamma
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22617429
NCBI chr12:65,663,764...65,668,732
Ensembl chr12:68,448,861...68,453,829
G
C
Ifng
interferon gamma
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22617429
NCBI chrNW_004955458:14,643,333...14,648,020
Ensembl chrNW_004955458:14,643,313...14,648,045
G
R
Ifng
interferon gamma
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22617429
NCBI chr 7:55,789,180...55,793,216
Ensembl chr 7:53,903,337...53,907,375
G
M
Ifng
interferon gamma
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22617429
NCBI chr10:118,276,951...118,281,799
Ensembl chr10:118,276,951...118,281,797
G
H
IFNG
interferon gamma
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:22617429
NCBI chr12:68,154,768...68,159,740
Ensembl chr12:68,154,768...68,159,740
G
N
Il17a
interleukin 17A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22617429
NCBI chrNW_004624855:3,911,349...3,914,214
Ensembl chrNW_004624855:3,911,349...3,913,136
G
G
IL17A
interleukin 17A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22617429
NCBI chr17:20,314,082...20,319,917
Ensembl chr17:20,315,773...20,318,785
G
P
IL17A
interleukin 17A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22617429
NCBI chr 7:46,013,584...46,017,161
Ensembl chr 7:46,013,584...46,017,153
G
S
Il17a
interleukin 17A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22617429
NCBI chrNW_004936476:8,621,860...8,625,008
Ensembl chrNW_004936476:8,621,860...8,625,008
G
D
IL17A
interleukin 17A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22617429
NCBI chr12:19,854,129...19,862,521
Ensembl chr12:19,854,129...19,862,513
G
B
IL17A
interleukin 17A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22617429
NCBI chr 6:51,736,269...51,740,538
Ensembl chr 6:53,004,820...53,009,074
G
C
Il17a
interleukin 17A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22617429
NCBI chrNW_004955411:5,896,435...5,899,911
Ensembl chrNW_004955411:5,896,702...5,900,962
G
R
Il17a
interleukin 17A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22617429
NCBI chr 9:30,640,844...30,644,331
Ensembl chr 9:23,144,402...23,147,889
G
M
Il17a
interleukin 17A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22617429
NCBI chr 1:20,801,129...20,804,720
Ensembl chr 1:20,801,129...20,804,720
G
H
IL17A
interleukin 17A
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:22617429
NCBI chr 6:52,186,375...52,190,638
Ensembl chr 6:52,186,375...52,190,638
G
N
Il18bp
interleukin 18 binding protein
ISO
ClinVar Annotator: match by term: Acute promyelocytic leukemia
ClinVar
PMID:25741868 PMID:28492532
NCBI chrNW_004624817:4,963,586...4,967,122
Ensembl chrNW_004624817:4,964,403...4,965,944
G
G
IL18BP
interleukin 18 binding protein
ISO
ClinVar Annotator: match by term: Acute promyelocytic leukemia
ClinVar
PMID:25741868 PMID:28492532
NCBI chr 1:63,199,412...63,204,615
Ensembl chr 1:63,200,284...63,203,934
G
P
IL18BP
interleukin 18 binding protein
ISO
ClinVar Annotator: match by term: Acute promyelocytic leukemia
ClinVar
PMID:25741868 PMID:28492532
NCBI chr 9:6,586,602...6,596,423
Ensembl chr 9:6,488,808...6,591,333
G
S
Il18bp
interleukin 18 binding protein
ISO
ClinVar Annotator: match by term: Acute promyelocytic leukemia
ClinVar
PMID:25741868 PMID:28492532
NCBI chrNW_004936498:1,353,569...1,358,312
Ensembl chrNW_004936498:1,355,749...1,361,117
G
D
IL18BP
interleukin 18 binding protein
ISO
ClinVar Annotator: match by term: Acute promyelocytic leukemia
ClinVar
PMID:25741868 PMID:28492532
NCBI chr21:26,076,515...26,080,741
Ensembl chr21:26,076,700...26,078,612
G
B
IL18BP
interleukin 18 binding protein
ISO
ClinVar Annotator: match by term: Acute promyelocytic leukemia
ClinVar
PMID:25741868 PMID:28492532
NCBI chr11:67,078,251...67,083,043
Ensembl chr11:70,302,923...70,307,511
G
C
Il18bp
interleukin 18 binding protein
ISO
ClinVar Annotator: match by term: Acute promyelocytic leukemia
ClinVar
PMID:25741868 PMID:28492532
NCBI chrNW_004955414:19,327,828...19,332,577
G
R
Il18bp
interleukin 18 binding protein
ISO
ClinVar Annotator: match by term: Acute promyelocytic leukemia
ClinVar
PMID:25741868 PMID:28492532
NCBI chr 1:165,784,916...165,787,990
Ensembl chr 1:156,372,883...156,374,963
G
M
Il18bp
interleukin 18 binding protein
ISO
ClinVar Annotator: match by term: Acute promyelocytic leukemia
ClinVar
PMID:25741868 PMID:28492532
NCBI chr 7:101,664,281...101,669,699
Ensembl chr 7:101,664,092...101,667,897
G
H
IL18BP
interleukin 18 binding protein
IAGP
ClinVar Annotator: match by term: Acute promyelocytic leukemia
ClinVar
PMID:25741868 PMID:28492532
NCBI chr11:71,998,909...72,008,200
Ensembl chr11:71,998,613...72,007,315
G
N
Irf2bp2
interferon regulatory factor 2 binding protein 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25583766
NCBI chrNW_004624775:15,479,808...15,484,855
Ensembl chrNW_004624775:15,482,630...15,484,824
G
G
IRF2BP2
interferon regulatory factor 2 binding protein 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25583766
NCBI chr25:71,774,447...71,779,759
Ensembl chr25:71,773,588...71,779,835
G
P
IRF2BP2
interferon regulatory factor 2 binding protein 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25583766
NCBI chr14:56,545,792...56,551,131
Ensembl chr14:56,545,685...56,551,125
G
S
Irf2bp2
interferon regulatory factor 2 binding protein 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25583766
NCBI chrNW_004936484:17,653,519...17,661,811
Ensembl chrNW_004936484:17,655,241...17,659,553
G
D
IRF2BP2
interferon regulatory factor 2 binding protein 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25583766
NCBI chr 4:5,242,225...5,249,371
Ensembl chr 4:5,244,869...5,247,247
G
B
IRF2BP2
interferon regulatory factor 2 binding protein 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25583766
NCBI chr 1:210,143,516...210,148,878
G
C
Irf2bp2
interferon regulatory factor 2 binding protein 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25583766
NCBI chrNW_004955492:4,889,878...4,895,508
Ensembl chrNW_004955492:4,889,878...4,894,325
G
R
Irf2bp2
interferon regulatory factor 2 binding protein 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25583766
NCBI chr19:71,456,689...71,462,368
Ensembl chr19:54,560,128...54,566,642
G
M
Irf2bp2
interferon regulatory factor 2 binding protein 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25583766
NCBI chr 8:127,315,035...127,320,725
Ensembl chr 8:127,315,035...127,320,725
G
H
IRF2BP2
interferon regulatory factor 2 binding protein 2
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:25583766
NCBI chr 1:234,604,269...234,610,178
Ensembl chr 1:234,602,300...234,610,178
G
N
Itgal
integrin subunit alpha L
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16764927
NCBI chrNW_004624782:13,635,217...13,671,401
Ensembl chrNW_004624782:13,640,996...13,669,541
G
G
ITGAL
integrin subunit alpha L
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16764927
NCBI chr 5:27,157,866...27,206,802
Ensembl chr 5:27,157,878...27,206,714
G
P
ITGAL
integrin subunit alpha L
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16764927
NCBI chr 3:17,817,785...17,858,057
Ensembl chr 3:17,817,011...17,858,012
G
S
Itgal
integrin subunit alpha L
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16764927
NCBI chrNW_004936501:12,921,509...12,966,791
Ensembl chrNW_004936501:12,922,642...12,966,663
G
D
ITGAL
integrin subunit alpha L
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16764927
NCBI chr 6:17,605,611...17,645,134
Ensembl chr 6:17,605,760...17,644,986
G
B
ITGAL
integrin subunit alpha L
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16764927
NCBI chr16:24,445,966...24,496,037
Ensembl chr16:30,843,747...30,892,597
G
C
Itgal
integrin subunit alpha L
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16764927
NCBI chrNW_004955493:7,397,813...7,435,420
Ensembl chrNW_004955493:7,397,991...7,439,070
G
R
Itgal
integrin subunit alpha L
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16764927
NCBI chr 1:191,348,424...191,386,228
Ensembl chr 1:181,918,183...181,955,732
G
M
Itgal
integrin alpha L
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16764927
NCBI chr 7:126,895,404...126,934,309
Ensembl chr 7:126,895,432...126,934,310
G
H
ITGAL
integrin subunit alpha L
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:16764927
NCBI chr16:30,472,742...30,523,185
Ensembl chr16:30,472,658...30,523,567
G
N
Itgam
integrin subunit alpha M
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16764927
NCBI chrNW_004624782:14,316,505...14,367,841
Ensembl chrNW_004624782:14,318,499...14,367,922
G
G
ITGAM
integrin subunit alpha M
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16764927
NCBI chr 5:27,957,162...28,042,697
Ensembl chr 5:27,957,324...28,042,691
G
P
ITGAM
integrin subunit alpha M
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16764927
NCBI chr 3:17,216,719...17,272,134
Ensembl chr 3:17,204,610...17,268,018
G
S
Itgam
integrin subunit alpha M
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16764927
NCBI chrNW_004936543:8,460,526...8,508,524
Ensembl chrNW_004936543:8,461,307...8,508,524
G
D
ITGAM
integrin subunit alpha M
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16764927
NCBI chr 6:16,944,062...16,996,525
Ensembl chr 6:16,808,971...16,996,286
G
B
ITGAM
integrin subunit alpha M
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16764927
NCBI chr16:23,634,476...23,707,147
Ensembl chr16:31,630,146...31,702,406
G
C
Itgam
integrin subunit alpha M
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16764927
NCBI chrNW_004955493:8,116,886...8,160,806
Ensembl chrNW_004955493:8,116,834...8,260,759
G
R
Itgam
integrin subunit alpha M
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16764927
NCBI chr 1:192,089,496...192,139,947
Ensembl chr 1:182,659,000...182,709,503
G
M
Itgam
integrin alpha M
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16764927
NCBI chr 7:127,661,812...127,717,663
Ensembl chr 7:127,661,812...127,717,663
G
H
ITGAM
integrin subunit alpha M
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:16764927
NCBI chr16:31,259,975...31,332,877
Ensembl chr16:31,259,967...31,332,892
G
N
Itgax
integrin subunit alpha X
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16764927
NCBI chrNW_004624782:14,380,234...14,397,552
Ensembl chrNW_004624782:14,380,399...14,395,916
G
G
ITGAX
integrin subunit alpha X
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16764927
NCBI chr 5:28,058,172...28,087,253
Ensembl chr 5:28,058,456...28,086,838
G
P
ITGAX
integrin subunit alpha X
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16764927
NCBI chr 3:17,178,725...17,201,388
G
S
Itgax
integrin subunit alpha X
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16764927
NCBI chrNW_004936543:8,424,095...8,442,850
Ensembl chrNW_004936543:8,424,672...8,442,850
G
D
ITGAX
integrin subunit alpha X
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16764927
NCBI chr 6:16,898,143...16,927,270
Ensembl chr 6:16,808,971...16,996,286
G
B
ITGAX
integrin subunit alpha X
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16764927
NCBI chr16:23,574,807...23,612,638
Ensembl chr16:31,724,113...31,797,249
G
C
Itgax
integrin subunit alpha X
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16764927
NCBI chrNW_004955493:8,196,593...8,220,296
G
R
Itgax
integrin subunit alpha X
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16764927
NCBI chr 1:192,140,089...192,171,151
Ensembl chr 1:182,719,609...182,740,698
G
M
Itgax
integrin alpha X
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16764927
NCBI chr 7:127,728,697...127,749,829
Ensembl chr 7:127,728,719...127,749,829
G
H
ITGAX
integrin subunit alpha X
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:16764927
NCBI chr16:31,355,176...31,382,999
Ensembl chr16:31,355,134...31,382,999
G
N
Itgb2
integrin subunit beta 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16764927
NCBI chrNW_004624745:30,452,576...30,479,036
Ensembl chrNW_004624745:30,452,576...30,470,611
G
G
ITGB2
integrin subunit beta 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16764927
NCBI chr 2:88,597,554...88,644,890
Ensembl chr 2:88,597,556...88,624,025
G
P
ITGB2
integrin subunit beta 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16764927
NCBI chr13:207,514,281...207,544,108
Ensembl chr13:207,512,950...207,544,107
G
S
Itgb2
integrin subunit beta 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16764927
NCBI chrNW_004936778:1,286,475...1,311,184
Ensembl chrNW_004936778:1,286,341...1,311,194
G
D
ITGB2
integrin subunit beta 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16764927
NCBI chr31:38,520,733...38,547,003
Ensembl chr31:38,521,103...38,547,018
G
B
ITGB2
integrin subunit beta 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16764927
NCBI chr21:31,181,228...31,216,033
Ensembl chr21:44,470,999...44,505,963
G
C
Itgb2
integrin subunit beta 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16764927
NCBI chrNW_004955407:41,779,849...41,805,637
Ensembl chrNW_004955407:41,777,777...41,800,201
G
R
Itgb2
integrin subunit beta 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16764927
NCBI chr20:11,061,009...11,097,242
Ensembl chr20:11,061,430...11,097,600
G
M
Itgb2
integrin beta 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16764927
NCBI chr10:77,366,164...77,401,542
Ensembl chr10:77,366,086...77,401,542
G
H
ITGB2
integrin subunit beta 2
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:16764927
NCBI chr21:44,885,953...44,928,815
Ensembl chr21:44,885,953...44,931,989
G
N
Kit
KIT proto-oncogene, receptor tyrosine kinase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26285909
NCBI chrNW_004624761:14,733,912...14,831,428
G
G
KIT
KIT proto-oncogene, receptor tyrosine kinase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26285909
NCBI chr 7:13,808,104...13,891,003
Ensembl chr 7:13,808,037...13,890,976
G
P
KIT
KIT proto-oncogene, receptor tyrosine kinase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26285909
NCBI chr 8:41,402,334...41,492,306
Ensembl chr 8:41,402,043...41,493,734
G
S
Kit
KIT proto-oncogene, receptor tyrosine kinase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26285909
NCBI chrNW_004936482:17,162,854...17,238,319
Ensembl chrNW_004936482:17,162,950...17,238,274
G
D
KIT
KIT proto-oncogene, receptor tyrosine kinase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26285909
NCBI chr13:47,108,442...47,190,935
Ensembl chr13:47,108,504...47,190,029
G
B
KIT
KIT proto-oncogene, receptor tyrosine kinase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26285909
NCBI chr 4:69,199,543...69,282,323
Ensembl chr 4:75,761,946...75,844,473
G
C
Kit
KIT proto-oncogene, receptor tyrosine kinase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26285909
NCBI chrNW_004955447:16,149,014...16,226,151
Ensembl chrNW_004955447:16,148,605...16,226,734
G
R
Kit
KIT proto-oncogene receptor tyrosine kinase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26285909
NCBI chr14:32,901,615...32,978,895
Ensembl chr14:32,548,877...32,624,652
G
M
Kit
KIT proto-oncogene receptor tyrosine kinase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26285909
NCBI chr 5:75,735,647...75,817,382
Ensembl chr 5:75,735,576...75,817,382
G
H
KIT
KIT proto-oncogene, receptor tyrosine kinase
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:26285909
NCBI chr 4:54,657,957...54,740,715
Ensembl chr 4:54,657,267...54,740,783
G
N
Kmt2e
lysine methyltransferase 2E (inactive)
severity
ISO
mRNA:decreased expression:peripheral blood, bone marrow, mononuclear cells (human)
RGD
PMID:24796963
RGD:9588539
NCBI chrNW_004624739:24,371,415...24,476,245
Ensembl chrNW_004624739:24,372,237...24,476,137
G
G
KMT2E
lysine methyltransferase 2E (inactive)
severity
ISO
mRNA:decreased expression:peripheral blood, bone marrow, mononuclear cells (human)
RGD
PMID:24796963
RGD:9588539
NCBI chr21:73,930,957...74,030,434
Ensembl chr21:73,930,932...74,029,673
G
P
KMT2E
lysine methyltransferase 2E (inactive)
severity
ISO
mRNA:decreased expression:peripheral blood, bone marrow, mononuclear cells (human)
RGD
PMID:24796963
RGD:9588539
NCBI chr 9:104,876,301...105,007,161
Ensembl chr 9:104,911,821...105,007,084
G
S
Kmt2e
lysine methyltransferase 2E (inactive)
severity
ISO
mRNA:decreased expression:peripheral blood, bone marrow, mononuclear cells (human)
RGD
PMID:24796963
RGD:9588539
NCBI chrNW_004936479:18,674,657...18,764,177
Ensembl chrNW_004936479:18,675,413...18,738,983
G
D
KMT2E
lysine methyltransferase 2E (inactive)
severity
ISO
mRNA:decreased expression:peripheral blood, bone marrow, mononuclear cells (human)
RGD
PMID:24796963
RGD:9588539
NCBI chr18:15,240,631...15,332,850
Ensembl chr18:15,239,994...15,332,828
G
B
KMT2E
lysine methyltransferase 2E (inactive)
severity
ISO
mRNA:decreased expression:peripheral blood, bone marrow, mononuclear cells (human)
RGD
PMID:24796963
RGD:9588539
NCBI chr 7:97,001,250...97,099,956
Ensembl chr 7:109,734,808...109,832,851
G
C
Kmt2e
lysine methyltransferase 2E (inactive)
severity
ISO
mRNA:decreased expression:peripheral blood, bone marrow, mononuclear cells (human)
RGD
PMID:24796963
RGD:9588539
NCBI chrNW_004955410:9,714,587...9,808,021
G
R
Kmt2e
lysine methyltransferase 2E
severity
ISO
mRNA:decreased expression:peripheral blood, bone marrow, mononuclear cells (human)
RGD
PMID:24796963
RGD:9588539
NCBI chr 4:12,550,570...12,655,329
Ensembl chr 4:11,658,979...11,727,373
G
M
Kmt2e
lysine (K)-specific methyltransferase 2E
severity
ISO
mRNA:decreased expression:peripheral blood, bone marrow, mononuclear cells (human)
RGD
PMID:24796963
RGD:9588539
NCBI chr 5:23,638,034...23,709,233
Ensembl chr 5:23,639,439...23,709,233
G
H
KMT2E
lysine methyltransferase 2E (inactive)
severity
IEP
mRNA:decreased expression:peripheral blood, bone marrow, mononuclear cells (human)
RGD
PMID:24796963
RGD:9588539
NCBI chr 7:105,014,205...105,115,019
Ensembl chr 7:104,940,943...105,115,019
G
N
Lat2
linker for activation of T cells family member 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:32587277
NCBI chrNW_004624740:13,745,949...13,764,869
G
G
LAT2
linker for activation of T cells family member 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:32587277
NCBI chr28:8,848,971...8,865,558
Ensembl chr28:8,848,638...8,865,574
G
P
LAT2
linker for activation of T cells family member 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:32587277
NCBI chr 3:11,353,213...11,372,100
Ensembl chr 3:11,352,548...11,372,101
G
S
Lat2
linker for activation of T cells family member 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:32587277
NCBI chrNW_004936543:3,250,956...3,262,668
G
D
LAT2
linker for activation of T cells family member 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:32587277
NCBI chr 6:6,160,939...6,175,271
Ensembl chr 6:6,161,542...6,173,294
G
B
LAT2
linker for activation of T cells family member 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:32587277
Ensembl chr 7:81,350,666...81,377,115
G
C
Lat2
linker for activation of T cells family member 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:32587277
NCBI chrNW_004955456:13,674,190...13,688,611
G
R
Lat2
linker for activation of T cells family, member 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:32587277
NCBI chr12:22,104,173...22,118,294
Ensembl chr12:22,104,219...22,118,288
G
M
Lat2
linker for activation of T cells family, member 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:32587277
NCBI chr 5:134,628,957...134,648,637
Ensembl chr 5:134,628,876...134,643,879
G
H
LAT2
linker for activation of T cells family member 2
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:32587277
NCBI chr 7:74,210,006...74,229,834
Ensembl chr 7:74,199,652...74,229,834
G
N
Lep
leptin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:32929351
NCBI chrNW_004624783:7,708,820...7,721,610
Ensembl chrNW_004624783:7,708,588...7,721,727
G
G
LEP
leptin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:32929351
NCBI chr21:97,056,913...97,071,161
Ensembl chr21:97,057,529...97,071,220
G
P
LEP
leptin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:32929351
NCBI chr18:20,106,867...20,124,071
Ensembl chr18:20,106,868...20,123,323
G
S
Lep
leptin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:32929351
NCBI chrNW_004936479:15,394,966...15,411,334
Ensembl chrNW_004936479:15,394,966...15,411,334
G
D
LEP
leptin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:32929351
NCBI chr14:8,115,396...8,130,946
Ensembl chr14:8,116,122...8,131,395
G
B
LEP
leptin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:32929351
NCBI chr 7:120,230,896...120,248,602
Ensembl chr 7:132,885,011...132,901,519
G
C
Lep
leptin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:32929351
NCBI chrNW_004955479:9,266,604...9,276,568
Ensembl chrNW_004955479:9,274,516...9,279,472
G
R
Lep
leptin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:32929351
NCBI chr 4:58,626,529...58,640,663
Ensembl chr 4:57,661,131...57,675,262
G
M
Lep
leptin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:32929351
NCBI chr 6:29,060,220...29,073,875
Ensembl chr 6:29,060,219...29,073,876
G
H
LEP
leptin
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:32929351
NCBI chr 7:128,241,278...128,257,629
Ensembl chr 7:128,241,278...128,257,629
G
S
LOC101971285
7-dehydrocholesterol reductase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:32929351
NCBI chrNW_004936794:1,432,379...1,468,966
G
G
LOC103231165
isocitrate dehydrogenase (NADP(+)) 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26285909
NCBI chr29:8,633,429...8,650,744
Ensembl chr29:8,633,715...8,650,657
G
H
LOC129934333
ATAC-STARR-seq lymphoblastoid silent region 11759
IAGP
ClinVar Annotator: match by term: Acute promyelocytic leukemia
ClinVar
PMID:25741868 PMID:28492532 PMID:32575117
NCBI chr 2:96,265,257...96,265,566
G
N
Ltc4s
leukotriene C4 synthase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:32929351
NCBI chrNW_004624733:42,668,963...42,673,385
Ensembl chrNW_004624733:42,670,632...42,672,846
G
G
LTC4S
leukotriene C4 synthase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:32929351
NCBI chr23:81,523,784...81,526,297
Ensembl chr23:81,523,775...81,526,179
G
P
LTC4S
leukotriene C4 synthase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:32929351
NCBI chr 2:78,799,446...78,802,281
Ensembl chr 2:78,799,449...78,802,285
G
S
Ltc4s
leukotriene C4 synthase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:32929351
NCBI chrNW_004936739:975,494...978,426
Ensembl chrNW_004936739:975,493...978,482
G
D
LTC4S
leukotriene C4 synthase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:32929351
NCBI chr11:1,893,927...1,897,028
Ensembl chr11:1,894,380...1,897,752
G
B
LTC4S
leukotriene C4 synthase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:32929351
NCBI chr 5:174,946,346...174,950,805
G
C
Ltc4s
leukotriene C4 synthase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:32929351
NCBI chrNW_004955408:788,856...791,505
G
R
Ltc4s
leukotriene C4 synthase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:32929351
NCBI chr10:35,060,002...35,066,466
Ensembl chr10:34,560,360...34,562,651
G
M
Ltc4s
leukotriene C4 synthase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:32929351
NCBI chr11:50,127,288...50,129,378
Ensembl chr11:50,127,288...50,129,443
G
H
LTC4S
leukotriene C4 synthase
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:32929351
NCBI chr 5:179,793,986...179,796,647
Ensembl chr 5:179,793,980...179,796,647
G
N
Me1
malic enzyme 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:32929351
NCBI chrNW_004624799:11,166,398...11,382,662
G
G
ME1
malic enzyme 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:32929351
NCBI chr13:7,889,211...8,112,793
Ensembl chr13:7,887,984...8,112,533
G
P
ME1
malic enzyme 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:32929351
NCBI chr 1:82,799,878...82,989,895
Ensembl chr 1:82,799,684...82,991,085
G
S
Me1
malic enzyme 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:32929351
NCBI chrNW_004936510:7,425,983...7,571,090
Ensembl chrNW_004936510:7,426,347...7,571,553
G
D
ME1
malic enzyme 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:32929351
NCBI chr12:43,623,413...43,793,590
Ensembl chr12:43,624,945...43,828,775
G
B
ME1
malic enzyme 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:32929351
NCBI chr 6:81,107,569...81,320,050
Ensembl chr 6:84,382,732...84,595,701
G
C
Me1
malic enzyme 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:32929351
NCBI chrNW_004955411:10,938,580...11,084,171
Ensembl chrNW_004955411:10,938,944...11,065,085
G
R
Me1
malic enzyme 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:32929351
NCBI chr 8:96,429,057...96,540,244
Ensembl chr 8:87,549,043...87,660,304
G
M
Me1
malic enzyme 1, NADP(+)-dependent, cytosolic
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:32929351
NCBI chr 9:86,463,416...86,577,967
Ensembl chr 9:86,463,424...86,578,006
G
H
ME1
malic enzyme 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:32929351
NCBI chr 6:83,210,402...83,431,051
Ensembl chr 6:83,210,402...83,431,051
G
P
MIR15A
microRNA mir-15a
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:21056550
NCBI chr11:17,757,463...17,757,541
Ensembl chr11:17,757,460...17,757,554
G
D
MIR15A
microRNA mir-15a
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:21056550
NCBI chr22:1,846,880...1,846,938
Ensembl chr22:1,846,866...1,846,960
G
M
Mir15a
microRNA 15a
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:21056550
NCBI chr14:61,869,476...61,869,559
Ensembl chr14:61,869,476...61,869,559
G
H
MIR15A
microRNA 15a
EXP
CTD Direct Evidence: therapeutic
CTD
PMID:21056550
NCBI chr13:50,049,119...50,049,201
Ensembl chr13:50,049,119...50,049,201
G
D
MIR16-1
microRNA mir-16-1
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:21056550
NCBI chr22:1,847,020...1,847,084
Ensembl chr22:1,847,007...1,847,093
G
M
Mir16-1
microRNA 16-1
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:21056550
NCBI chr14:61,869,329...61,869,421
Ensembl chr14:61,869,329...61,869,421
G
H
MIR16-1
microRNA 16-1
EXP
CTD Direct Evidence: therapeutic
CTD
PMID:21056550
NCBI chr13:50,048,973...50,049,061
Ensembl chr13:50,048,973...50,049,061
G
P
MIR16-2
microRNA mir-16-2
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:21056550
NCBI chr11:17,757,606...17,757,684
Ensembl chr11:17,757,601...17,757,687
G
N
Mtarc2
mitochondrial amidoxime reducing component 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:32929351
NCBI chrNW_004624835:4,146,910...4,163,292
Ensembl chrNW_004624835:4,146,766...4,163,430
G
G
MTARC2
mitochondrial amidoxime reducing component 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:32929351
NCBI chr25:8,745,754...8,782,967
Ensembl chr25:8,748,605...8,782,379
G
P
MTARC2
mitochondrial amidoxime reducing component 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:32929351
NCBI chr10:10,156,732...10,194,371
Ensembl chr10:10,156,728...10,189,924
G
S
Mtarc2
mitochondrial amidoxime reducing component 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:32929351
NCBI chrNW_004936650:1,506,471...1,543,532
Ensembl chrNW_004936650:1,506,329...1,543,712
G
D
MTARC2
mitochondrial amidoxime reducing component 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:32929351
NCBI chr38:15,426,884...15,451,701
Ensembl chr38:15,426,666...15,451,136
G
B
MTARC2
mitochondrial amidoxime reducing component 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:32929351
NCBI chr 1:196,333,803...196,371,147
Ensembl chr 1:201,369,424...201,405,602
G
R
Mtarc2
mitochondrial amidoxime reducing component 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:32929351
NCBI chr13:98,894,347...98,928,754
G
M
Mtarc2
mitochondrial amidoxime reducing component 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:32929351
NCBI chr 1:184,545,263...184,579,266
Ensembl chr 1:184,545,265...184,578,648
G
H
MTARC2
mitochondrial amidoxime reducing component 2
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:32929351
NCBI chr 1:220,748,322...220,784,815
Ensembl chr 1:220,748,225...220,784,815
G
N
Myc
MYC proto-oncogene, bHLH transcription factor
onset
ISO
mRNA:increased expression:promyelocyte:
RGD
PMID:21059853
RGD:11532756
NCBI chrNW_004624735:27,780,338...27,784,714
Ensembl chrNW_004624735:27,780,037...27,784,806
G
G
MYC
MYC proto-oncogene, bHLH transcription factor
onset
ISO
mRNA:increased expression:promyelocyte:
RGD
PMID:21059853
RGD:11532756
NCBI chr 8:122,282,989...122,288,392
Ensembl chr 8:122,282,630...122,288,384
G
P
MYC
MYC proto-oncogene, bHLH transcription factor
onset
ISO
mRNA:increased expression:promyelocyte:
RGD
PMID:21059853
RGD:11532756
NCBI chr 4:12,455,141...12,460,360
Ensembl chr 4:12,455,122...12,461,078
G
S
Myc
MYC proto-oncogene, bHLH transcription factor
onset
ISO
mRNA:increased expression:promyelocyte:
RGD
PMID:21059853
RGD:11532756
NCBI chrNW_004936470:20,480,844...20,485,955
Ensembl chrNW_004936470:20,480,829...20,485,965
G
D
MYC
MYC proto-oncogene, bHLH transcription factor
onset
ISO
mRNA:increased expression:promyelocyte:
RGD
PMID:21059853
RGD:11532756
NCBI chr13:25,200,772...25,205,309
Ensembl chr13:25,200,577...25,205,309
G
B
MYC
MYC proto-oncogene, bHLH transcription factor
onset
ISO
mRNA:increased expression:promyelocyte:
RGD
PMID:21059853
RGD:11532756
NCBI chr 8:124,387,561...124,393,551
Ensembl chr 8:127,131,512...127,136,863
G
C
Myc
MYC proto-oncogene, bHLH transcription factor
onset
ISO
mRNA:increased expression:promyelocyte:
RGD
PMID:21059853
RGD:11532756
NCBI chrNW_004955461:2,714,022...2,718,872
Ensembl chrNW_004955461:2,714,022...2,718,982
G
R
Myc
MYC proto-oncogene, bHLH transcription factor
onset
ISO
mRNA:increased expression:promyelocyte:
RGD
PMID:21059853 PMID:21059853
RGD:11532756 , RGD:11532756
NCBI chr 7:95,483,105...95,488,031
Ensembl chr 7:93,593,705...93,598,630
G
M
Myc
myelocytomatosis oncogene
onset
ISO
mRNA:increased expression:promyelocyte:
RGD
PMID:21059853 PMID:21059853
RGD:11532756 , RGD:11532756
NCBI chr15:61,857,190...61,862,210
Ensembl chr15:61,857,240...61,862,223
G
H
MYC
MYC proto-oncogene, bHLH transcription factor
onset
IMP IEP
mRNA:increased expression:promyelocyte:
RGD
PMID:21059853 PMID:21059853
RGD:11532756 , RGD:11532756
NCBI chr 8:127,735,434...127,742,951
Ensembl chr 8:127,735,434...127,742,951
G
N
Ncam1
neural cell adhesion molecule 1
disease_progression
ISO
RGD
PMID:24296270
RGD:40907062
NCBI chrNW_004624784:8,339,582...8,635,025
Ensembl chrNW_004624784:8,339,916...8,636,012
G
G
NCAM1
neural cell adhesion molecule 1
disease_progression
ISO
RGD
PMID:24296270
RGD:40907062
NCBI chr 1:104,332,622...104,647,258
G
P
NCAM1
neural cell adhesion molecule 1
disease_progression
ISO
RGD
PMID:24296270
RGD:40907062
NCBI chr 9:40,628,602...40,960,605
Ensembl chr 9:40,628,631...40,960,591
G
S
Ncam1
neural cell adhesion molecule 1
disease_progression
ISO
RGD
PMID:24296270
RGD:40907062
NCBI chrNW_004936612:1,262,557...1,556,281
Ensembl chrNW_004936612:1,262,544...1,556,016
G
D
NCAM1
neural cell adhesion molecule 1
disease_progression
ISO
RGD
PMID:24296270
RGD:40907062
NCBI chr 5:19,895,587...20,192,334
Ensembl chr 5:19,895,613...20,191,995
G
B
NCAM1
neural cell adhesion molecule 1
disease_progression
ISO
RGD
PMID:24296270
RGD:40907062
NCBI chr11:107,845,507...108,160,441
Ensembl chr11:111,925,677...112,000,401
G
C
Ncam1
neural cell adhesion molecule 1
disease_progression
ISO
RGD
PMID:24296270
RGD:40907062
NCBI chrNW_004955412:14,630,109...14,923,847
Ensembl chrNW_004955412:14,630,443...14,923,926
G
R
Ncam1
neural cell adhesion molecule 1
disease_progression
ISO
RGD
PMID:24296270
RGD:40907062
NCBI chr 8:58,762,088...59,062,131
Ensembl chr 8:49,865,633...50,166,014
G
M
Ncam1
neural cell adhesion molecule 1
disease_progression
ISO
RGD
PMID:24296270
RGD:40907062
NCBI chr 9:49,413,434...49,710,909
Ensembl chr 9:49,413,436...49,710,225
G
H
NCAM1
neural cell adhesion molecule 1
disease_progression
IEP
RGD
PMID:24296270
RGD:40907062
NCBI chr11:112,961,420...113,278,436
Ensembl chr11:112,961,275...113,278,436
G
N
Npm1
nucleophosmin 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:14508522 PMID:26285909
NCBI chrNW_004624733:18,645,269...18,655,073
G
G
NPM1
nucleophosmin 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:14508522 PMID:26285909
NCBI chr23:73,555,020...73,575,910
Ensembl chr23:73,555,260...73,575,925
G
P
NPM1
nucleophosmin 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:14508522 PMID:26285909
NCBI chr16:52,767,263...52,781,862
Ensembl chr16:52,765,298...52,781,771
G
S
Npm1
nucleophosmin 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:14508522 PMID:26285909
NCBI chrNW_004936609:3,712,628...3,725,635
G
D
NPM1
nucleophosmin 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:14508522 PMID:26285909
NCBI chr 4:40,756,464...40,770,174
Ensembl chr 4:40,756,465...40,770,175
G
B
NPM1
nucleophosmin 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:14508522 PMID:26285909
NCBI chr 5:166,735,904...166,756,321
Ensembl chr 5:173,490,197...173,510,656
G
C
Npm1
nucleophosmin 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:14508522 PMID:26285909
NCBI chrNW_004955408:24,151,070...24,218,783
G
R
Npm1
nucleophosmin 1
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:14508522 PMID:26285909 PMID:15659732
RGD:1600902
NCBI chr10:18,245,739...18,255,913
Ensembl chr10:17,739,941...17,751,645 Ensembl chr X:17,739,941...17,751,645
G
M
Npm1
nucleophosmin 1
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:14508522 PMID:26285909 PMID:15659732
RGD:1600902
NCBI chr11:33,102,498...33,114,143
Ensembl chr11:33,102,287...33,113,206
G
H
NPM1
nucleophosmin 1
TAS EXP
DNA:translocation:fusion_protein CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:14508522 PMID:26285909 PMID:15659732
RGD:1600902
NCBI chr 5:171,387,116...171,410,900
Ensembl chr 5:171,387,116...171,411,810
G
N
Nras
NRAS proto-oncogene, GTPase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26285909
NCBI chrNW_004624772:10,358,554...10,369,371
G
G
NRAS
NRAS proto-oncogene, GTPase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26285909
NCBI chr20:18,953,273...18,966,002
Ensembl chr20:18,953,883...18,961,931
G
P
NRAS
NRAS proto-oncogene, GTPase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26285909
NCBI chr 4:105,845,913...105,853,769
Ensembl chr 4:105,845,872...105,858,227
G
S
Nras
NRAS proto-oncogene, GTPase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26285909
NCBI chrNW_004936627:73,413...82,590
Ensembl chrNW_004936627:73,413...82,590
G
D
NRAS
NRAS proto-oncogene, GTPase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26285909
NCBI chr17:52,411,733...52,418,788
Ensembl chr17:52,411,733...52,418,788
G
B
NRAS
NRAS proto-oncogene, GTPase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26285909
NCBI chr 1:87,837,146...87,850,013
Ensembl chr 1:122,890,505...122,903,585
G
C
Nras
NRAS proto-oncogene, GTPase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26285909
NCBI chrNW_004955435:18,001,517...18,009,105
Ensembl chrNW_004955435:18,001,517...18,009,103
G
R
Nras
NRAS proto-oncogene, GTPase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26285909
NCBI chr 2:193,271,399...193,282,023
Ensembl chr 2:190,582,918...190,591,626
G
M
Nras
neuroblastoma ras oncogene
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26285909
NCBI chr 3:102,965,643...102,975,230
Ensembl chr 3:102,965,601...102,975,230
G
H
NRAS
NRAS proto-oncogene, GTPase
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:26285909
NCBI chr 1:114,704,469...114,716,771
Ensembl chr 1:114,704,469...114,716,771
G
N
Numa1
nuclear mitotic apparatus protein 1
ISO
ClinVar Annotator: match by term: Acute promyelocytic leukemia
ClinVar
PMID:25741868 PMID:28492532
NCBI chrNW_004624817:4,896,066...4,963,440
Ensembl chrNW_004624817:4,924,827...4,963,436
G
G
NUMA1
nuclear mitotic apparatus protein 1
ISO
ClinVar Annotator: match by term: Acute promyelocytic leukemia
ClinVar
PMID:25741868 PMID:28492532
NCBI chr 1:63,204,968...63,284,673
Ensembl chr 1:63,202,913...63,273,774
G
P
NUMA1
nuclear mitotic apparatus protein 1
ISO
ClinVar Annotator: match by term: Acute promyelocytic leukemia
ClinVar
PMID:25741868 PMID:28492532
NCBI chr 9:6,591,943...6,662,966
Ensembl chr 9:6,591,945...6,662,085
G
S
Numa1
nuclear mitotic apparatus protein 1
ISO
ClinVar Annotator: match by term: Acute promyelocytic leukemia
ClinVar
PMID:25741868 PMID:28492532
NCBI chrNW_004936498:1,358,598...1,438,041
Ensembl chrNW_004936498:1,359,285...1,438,382
G
D
NUMA1
nuclear mitotic apparatus protein 1
ISO
ClinVar Annotator: match by term: Acute promyelocytic leukemia
ClinVar
PMID:25741868 PMID:28492532
NCBI chr21:26,000,579...26,076,281
Ensembl chr21:26,037,095...26,075,549
G
B
NUMA1
nuclear mitotic apparatus protein 1
ISO
ClinVar Annotator: match by term: Acute promyelocytic leukemia
ClinVar
PMID:25741868 PMID:28492532
NCBI chr11:67,083,378...67,160,747
Ensembl chr11:70,307,847...70,384,425
G
C
Numa1
nuclear mitotic apparatus protein 1
ISO
ClinVar Annotator: match by term: Acute promyelocytic leukemia
ClinVar
PMID:25741868 PMID:28492532
NCBI chrNW_004955414:19,252,191...19,327,504
Ensembl chrNW_004955414:19,252,191...19,327,504
G
R
Numa1
nuclear mitotic apparatus protein 1
ISO
ClinVar Annotator: match by term: Acute promyelocytic leukemia
ClinVar
PMID:25741868 PMID:28492532
NCBI chr 1:165,709,893...165,784,848
Ensembl chr 1:156,326,259...156,372,855
G
M
Numa1
nuclear mitotic apparatus protein 1
ISO
ClinVar Annotator: match by term: Acute promyelocytic leukemia
ClinVar
PMID:25741868 PMID:28492532
NCBI chr 7:101,583,169...101,664,166
Ensembl chr 7:101,583,318...101,664,171
G
H
NUMA1
nuclear mitotic apparatus protein 1
IAGP
ClinVar Annotator: match by term: Acute promyelocytic leukemia
ClinVar
PMID:25741868 PMID:28492532
NCBI chr11:72,002,864...72,080,542
Ensembl chr11:72,002,864...72,080,693
G
N
Plat
plasminogen activator, tissue type
ISO
protein:increased expression:leukocyte (human)
RGD
PMID:10861807
RGD:11541060
NCBI chrNW_004624780:1,014,429...1,063,636
Ensembl chrNW_004624780:1,028,085...1,063,649
G
G
PLAT
plasminogen activator, tissue type
ISO
protein:increased expression:leukocyte (human)
RGD
PMID:10861807
RGD:11541060
NCBI chr 8:40,164,391...40,196,627
Ensembl chr 8:40,163,891...40,196,555
G
P
PLAT
plasminogen activator, tissue type
ISO
protein:increased expression:leukocyte (human)
RGD
PMID:10861807
RGD:11541060
NCBI chr17:11,195,599...11,223,821
Ensembl chr17:11,195,602...11,224,032
G
S
Plat
plasminogen activator, tissue type
ISO
protein:increased expression:leukocyte (human)
RGD
PMID:10861807
RGD:11541060
NCBI chrNW_004936785:476,200...503,371
Ensembl chrNW_004936785:476,078...503,321
G
D
PLAT
plasminogen activator, tissue type
ISO
protein:increased expression:leukocyte (human)
RGD
PMID:10861807
RGD:11541060
NCBI chr16:23,469,590...23,496,013
G
B
PLAT
plasminogen activator, tissue type
ISO
protein:increased expression:leukocyte (human)
RGD
PMID:10861807
RGD:11541060
NCBI chr 8:41,419,415...41,451,951
Ensembl chr 8:38,864,918...38,897,779
G
C
Plat
plasminogen activator, tissue type
ISO
protein:increased expression:leukocyte (human)
RGD
PMID:10861807
RGD:11541060
NCBI chrNW_004955536:730,962...754,333
Ensembl chrNW_004955536:730,981...756,394
G
R
Plat
plasminogen activator, tissue type
ISO
protein:increased expression:leukocyte (human)
RGD
PMID:10861807
RGD:11541060
NCBI chr16:75,943,061...76,022,037
Ensembl chr16:69,240,585...69,268,223
G
M
Plat
plasminogen activator, tissue
ISO
protein:increased expression:leukocyte (human)
RGD
PMID:10861807
RGD:11541060
NCBI chr 8:23,247,655...23,272,864
Ensembl chr 8:23,247,743...23,272,860
G
H
PLAT
plasminogen activator, tissue type
IEP
protein:increased expression:leukocyte (human)
RGD
PMID:10861807
RGD:11541060
NCBI chr 8:42,174,718...42,207,565
Ensembl chr 8:42,174,718...42,207,709
G
N
Pml
PML nuclear body scaffold
ISO
human PML/RARA gene fusion in a mouse model CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:8616088 PMID:9122233 PMID:10742073 PMID:14706140 PMID:16788101 PMID:16835227 PMID:16891316 PMID:16935935 PMID:17294898 PMID:17649720 PMID:19029980 PMID:19035177 PMID:19884644 PMID:19887701 PMID:21345080 PMID:21613260 PMID:22213200 PMID:23208507 PMID:23734343 PMID:26285909 PMID:26728337 PMID:32882258 PMID:32929351 More...
RGD:41404695
NCBI chrNW_004624781:464,858...498,146
Ensembl chrNW_004624781:464,658...497,775
G
G
PML
PML nuclear body scaffold
ISO
human PML/RARA gene fusion in a mouse model CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:8616088 PMID:9122233 PMID:10742073 PMID:14706140 PMID:16788101 PMID:16835227 PMID:16891316 PMID:16935935 PMID:17294898 PMID:17649720 PMID:19029980 PMID:19035177 PMID:19884644 PMID:19887701 PMID:21345080 PMID:21613260 PMID:22213200 PMID:23208507 PMID:23734343 PMID:26285909 PMID:26728337 PMID:32882258 PMID:32929351 More...
RGD:41404695
NCBI chr26:9,441,998...9,494,949
Ensembl chr26:9,451,112...9,494,931
G
P
PML
PML nuclear body scaffold
ISO
human PML/RARA gene fusion in a mouse model CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:8616088 PMID:9122233 PMID:10742073 PMID:14706140 PMID:16788101 PMID:16835227 PMID:16891316 PMID:16935935 PMID:17294898 PMID:17649720 PMID:19029980 PMID:19035177 PMID:19884644 PMID:19887701 PMID:21345080 PMID:21613260 PMID:22213200 PMID:23208507 PMID:23734343 PMID:26285909 PMID:26728337 PMID:32882258 PMID:32929351 More...
RGD:41404695
NCBI chr 7:59,405,044...59,450,155
Ensembl chr 7:59,405,053...59,450,105
G
S
Pml
PML nuclear body scaffold
ISO
human PML/RARA gene fusion in a mouse model CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:8616088 PMID:9122233 PMID:10742073 PMID:14706140 PMID:16788101 PMID:16835227 PMID:16891316 PMID:16935935 PMID:17294898 PMID:17649720 PMID:19029980 PMID:19035177 PMID:19884644 PMID:19887701 PMID:21345080 PMID:21613260 PMID:22213200 PMID:23208507 PMID:23734343 PMID:26285909 PMID:26728337 PMID:32882258 PMID:32929351 More...
RGD:41404695
NCBI chrNW_004936471:33,135,186...33,173,218
Ensembl chrNW_004936471:33,135,164...33,177,666
G
D
PML
PML nuclear body scaffold
ISO
human PML/RARA gene fusion in a mouse model CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:8616088 PMID:9122233 PMID:10742073 PMID:14706140 PMID:16788101 PMID:16835227 PMID:16891316 PMID:16935935 PMID:17294898 PMID:17649720 PMID:19029980 PMID:19035177 PMID:19884644 PMID:19887701 PMID:21345080 PMID:21613260 PMID:22213200 PMID:23208507 PMID:23734343 PMID:26285909 PMID:26728337 PMID:32882258 PMID:32929351 More...
RGD:41404695
NCBI chr30:37,232,337...37,278,434
Ensembl chr30:37,232,306...37,277,741
G
B
PML
PML nuclear body scaffold
ISO
human PML/RARA gene fusion in a mouse model CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:8616088 PMID:9122233 PMID:10742073 PMID:14706140 PMID:16788101 PMID:16835227 PMID:16891316 PMID:16935935 PMID:17294898 PMID:17649720 PMID:19029980 PMID:19035177 PMID:19884644 PMID:19887701 PMID:21345080 PMID:21613260 PMID:22213200 PMID:23208507 PMID:23734343 PMID:26285909 PMID:26728337 PMID:32882258 PMID:32929351 More...
RGD:41404695
NCBI chr15:52,903,874...52,955,151
Ensembl chr15:71,658,884...71,710,883
G
C
Pml
PML nuclear body scaffold
ISO
human PML/RARA gene fusion in a mouse model CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:8616088 PMID:9122233 PMID:10742073 PMID:14706140 PMID:16788101 PMID:16835227 PMID:16891316 PMID:16935935 PMID:17294898 PMID:17649720 PMID:19029980 PMID:19035177 PMID:19884644 PMID:19887701 PMID:21345080 PMID:21613260 PMID:22213200 PMID:23208507 PMID:23734343 PMID:26285909 PMID:26728337 PMID:32882258 PMID:32929351 More...
RGD:41404695
NCBI chrNW_004955450:3,654,854...3,692,057
Ensembl chrNW_004955450:3,656,498...3,692,406
G
R
Pml
PML nuclear body scaffold
ISO
human PML/RARA gene fusion in a mouse model CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:8616088 PMID:10742073 PMID:14706140 PMID:16788101 PMID:16835227 PMID:16891316 PMID:16935935 PMID:17294898 PMID:17649720 PMID:19029980 PMID:19035177 PMID:19884644 PMID:19887701 PMID:21345080 PMID:21613260 PMID:22213200 PMID:23208507 PMID:23734343 PMID:26285909 PMID:26728337 PMID:32882258 PMID:32929351 PMID:9122233 More...
RGD:41404695
NCBI chr 8:67,523,164...67,557,801
Ensembl chr 8:58,628,837...58,658,971
G
M
Pml
promyelocytic leukemia
ISO
human PML/RARA gene fusion in a mouse model CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:8616088 PMID:10742073 PMID:14706140 PMID:16788101 PMID:16835227 PMID:16891316 PMID:16935935 PMID:17294898 PMID:17649720 PMID:19029980 PMID:19035177 PMID:19884644 PMID:19887701 PMID:21345080 PMID:21613260 PMID:22213200 PMID:23208507 PMID:23734343 PMID:26285909 PMID:26728337 PMID:32882258 PMID:32929351 PMID:9122233 More...
RGD:41404695
NCBI chr 9:58,125,359...58,157,077
Ensembl chr 9:58,125,359...58,157,069
G
H
PML
PML nuclear body scaffold
IMP EXP
human PML/RARA gene fusion in a mouse model CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:8616088 PMID:10742073 PMID:14706140 PMID:16788101 PMID:16835227 PMID:16891316 PMID:16935935 PMID:17294898 PMID:17649720 PMID:19029980 PMID:19035177 PMID:19884644 PMID:19887701 PMID:21345080 PMID:21613260 PMID:22213200 PMID:23208507 PMID:23734343 PMID:26285909 PMID:26728337 PMID:32882258 PMID:32929351 PMID:9122233 More...
RGD:41404695
NCBI chr15:73,994,716...74,047,827
Ensembl chr15:73,994,673...74,047,827
G
N
Pparg
peroxisome proliferator activated receptor gamma
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:32929351
NCBI chrNW_004624956:84,673...207,176
Ensembl chrNW_004624956:83,842...149,481
G
G
PPARG
peroxisome proliferator activated receptor gamma
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:32929351
NCBI chr22:48,262,743...48,407,415
Ensembl chr22:48,275,600...48,407,418
G
P
PPARG
peroxisome proliferator activated receptor gamma
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:32929351
NCBI chr13:68,301,566...68,433,951
Ensembl chr13:68,302,322...68,433,944
G
S
Pparg
peroxisome proliferator activated receptor gamma
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:32929351
NCBI chrNW_004936602:1,230,907...1,368,588
Ensembl chrNW_004936602:1,230,907...1,304,743
G
D
PPARG
peroxisome proliferator activated receptor gamma
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:32929351
NCBI chr20:6,134,618...6,265,481
Ensembl chr20:6,050,357...6,207,981
G
B
PPARG
peroxisome proliferator activated receptor gamma
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:32929351
NCBI chr 3:12,215,322...12,361,669
Ensembl chr 3:12,622,397...12,705,060
G
C
Pparg
peroxisome proliferator activated receptor gamma
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:32929351
NCBI chrNW_004955429:14,814,690...14,936,869
Ensembl chrNW_004955429:14,873,908...14,937,387
G
R
Pparg
peroxisome proliferator-activated receptor gamma
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:32929351
NCBI chr 4:150,095,743...150,221,104
Ensembl chr 4:148,423,194...148,548,468
G
M
Pparg
peroxisome proliferator activated receptor gamma
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:32929351
NCBI chr 6:115,337,828...115,467,365
Ensembl chr 6:115,337,912...115,467,360
G
H
PPARG
peroxisome proliferator activated receptor gamma
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:32929351
NCBI chr 3:12,287,368...12,434,344
Ensembl chr 3:12,287,368...12,434,356
G
N
Prame
PRAME nuclear receptor transcriptional regulator
severity
ISO
mRNA:increased expression:bone marrow (human)
RGD
PMID:18815192
RGD:11535037
NCBI chrNW_004624747:8,914,226...8,927,648
Ensembl chrNW_004624747:8,913,531...8,918,222
G
P
PRAME
PRAME nuclear receptor transcriptional regulator
severity
ISO
mRNA:increased expression:bone marrow (human)
RGD
PMID:18815192
RGD:11535037
NCBI chr14:48,901,097...48,906,855
Ensembl chr14:48,899,343...48,911,231
G
S
Prame
PRAME nuclear receptor transcriptional regulator
severity
ISO
mRNA:increased expression:bone marrow (human)
RGD
PMID:18815192
RGD:11535037
NCBI chrNW_004936619:1,748,337...1,751,748
G
D
PRAME
PRAME nuclear receptor transcriptional regulator
severity
ISO
mRNA:increased expression:bone marrow (human)
RGD
PMID:18815192
RGD:11535037
NCBI chr26:27,124,901...27,137,772
Ensembl chr26:27,124,902...27,136,112
G
C
Prame
PRAME nuclear receptor transcriptional regulator
severity
ISO
mRNA:increased expression:bone marrow (human)
RGD
PMID:18815192
RGD:11535037
NCBI chrNW_004955455:6,921,420...6,930,453
Ensembl chrNW_004955455:6,921,052...6,930,537
G
H
PRAME
PRAME nuclear receptor transcriptional regulator
severity
IEP
mRNA:increased expression:bone marrow (human)
RGD
PMID:18815192
RGD:11535037
NCBI chr22:22,547,701...22,559,265
Ensembl chr22:22,547,701...22,559,361
G
R
Pramex1
PRAME like, X-linked 1
severity
ISO
mRNA:increased expression:bone marrow (human)
RGD
PMID:18815192
RGD:11535037
NCBI chr X:102,862,457...102,867,725
Ensembl chr X:98,569,415...98,572,096
G
M
Pramex1
PRAME like, X-linked 1
severity
ISO
mRNA:increased expression:bone marrow (human)
RGD
PMID:18815192
RGD:11535037
NCBI chr X:134,513,662...134,528,437
Ensembl chr X:134,513,751...134,528,454
G
N
Prkar1a
protein kinase cAMP-dependent type I regulatory subunit alpha
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17712046
NCBI chrNW_004624870:3,552,608...3,575,461
Ensembl chrNW_004624870:3,552,745...3,574,880
G
G
PRKAR1A
protein kinase cAMP-dependent type I regulatory subunit alpha
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17712046
NCBI chr16:53,021,666...53,042,594
Ensembl chr16:53,023,963...53,042,493
G
P
PRKAR1A
protein kinase cAMP-dependent type I regulatory subunit alpha
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17712046
NCBI chr12:11,662,344...11,681,490
Ensembl chr12:11,662,347...11,681,373
G
S
Prkar1a
protein kinase cAMP-dependent type I regulatory subunit alpha
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17712046
NCBI chrNW_004936541:7,845,876...7,863,677
Ensembl chrNW_004936541:7,845,676...7,863,709
G
D
PRKAR1A
protein kinase cAMP-dependent type I regulatory subunit alpha
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17712046
NCBI chr 9:15,180,940...15,203,035
Ensembl chr 9:15,181,393...15,200,683
G
B
PRKAR1A
protein kinase cAMP-dependent type I regulatory subunit alpha
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17712046
NCBI chr17:62,448,718...62,488,493
Ensembl chr17:67,838,484...67,877,943
G
C
Prkar1a
protein kinase cAMP-dependent type I regulatory subunit alpha
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17712046
NCBI chrNW_004955478:4,241,283...4,262,119
Ensembl chrNW_004955478:4,241,283...4,263,087
G
R
Prkar1a
protein kinase cAMP-dependent type I regulatory subunit alpha
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17712046
NCBI chr10:95,120,537...95,139,028
Ensembl chr10:94,620,039...94,639,041
G
M
Prkar1a
protein kinase, cAMP dependent regulatory, type I, alpha
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17712046
NCBI chr11:109,539,849...109,560,489
Ensembl chr11:109,540,231...109,560,482
G
H
PRKAR1A
protein kinase cAMP-dependent type I regulatory subunit alpha
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:17712046
NCBI chr17:68,413,623...68,551,316
Ensembl chr17:68,511,780...68,551,319
G
N
Ptpn11
protein tyrosine phosphatase non-receptor type 11
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:32417439
NCBI chrNW_004624747:19,721,581...19,813,639
Ensembl chrNW_004624747:19,721,468...19,813,670
G
G
PTPN11
protein tyrosine phosphatase non-receptor type 11
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:32417439
NCBI chr11:107,658,495...107,754,457
Ensembl chr11:107,658,453...107,752,637
G
P
PTPN11
protein tyrosine phosphatase non-receptor type 11
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:32417439
NCBI chr14:39,202,165...39,292,041
Ensembl chr14:39,202,169...39,292,003
G
S
Ptpn11
protein tyrosine phosphatase non-receptor type 11
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:32417439
NCBI chrNW_004936668:2,602,261...2,687,903
Ensembl chrNW_004936668:2,628,706...2,682,448
G
D
PTPN11
protein tyrosine phosphatase non-receptor type 11
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:32417439
NCBI chr26:9,989,218...10,072,245
Ensembl chr26:9,989,425...10,067,481
G
B
PTPN11
protein tyrosine phosphatase non-receptor type 11
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:32417439
NCBI chr12:110,016,364...110,107,462
Ensembl chr12:113,435,669...113,503,762
G
C
Ptpn11
protein tyrosine phosphatase non-receptor type 11
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:32417439
NCBI chrNW_004955482:8,934,734...9,031,230
Ensembl chrNW_004955482:8,934,306...9,035,203
G
R
Ptpn11
protein tyrosine phosphatase, non-receptor type 11
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:32417439
NCBI chr12:41,026,079...41,085,577
Ensembl chr12:35,383,144...35,424,925
G
M
Ptpn11
protein tyrosine phosphatase, non-receptor type 11
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:32417439
NCBI chr 5:121,268,596...121,329,460
Ensembl chr 5:121,268,596...121,329,460
G
H
PTPN11
protein tyrosine phosphatase non-receptor type 11
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:32417439
NCBI chr12:112,418,947...112,509,918
Ensembl chr12:112,418,351...112,509,918
G
N
Rap1gap
RAP1 GTPase activating protein
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22614916
NCBI chrNW_004624764:6,460,230...6,521,693
Ensembl chrNW_004624764:6,460,230...6,506,741
G
G
RAP1GAP
RAP1 GTPase activating protein
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22614916
NCBI chr20:110,967,457...111,040,940
Ensembl chr20:110,987,308...111,040,947
G
P
RAP1GAP
RAP1 GTPase activating protein
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22614916
NCBI chr 6:79,664,486...79,735,361
Ensembl chr 6:79,664,485...79,735,361
G
S
Rap1gap
RAP1 GTPase activating protein
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22614916
NCBI chrNW_004936474:7,242,528...7,284,342
Ensembl chrNW_004936474:7,242,824...7,284,395
G
D
RAP1GAP
RAP1 GTPase activating protein
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22614916
NCBI chr 2:77,509,592...77,554,620
Ensembl chr 2:77,527,914...77,544,205
G
B
RAP1GAP
RAP1 GTPase activating protein
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22614916
NCBI chr 1:20,790,076...20,860,511
Ensembl chr 1:21,754,733...21,824,405
G
C
Rap1gap
RAP1 GTPase activating protein
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22614916
NCBI chrNW_004955452:1,886,557...1,950,942
Ensembl chrNW_004955452:1,886,557...1,933,977
G
R
Rap1gap
Rap1 GTPase-activating protein
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22614916
NCBI chr 5:155,157,511...155,222,622
Ensembl chr 5:149,892,019...149,939,253
G
M
Rap1gap
Rap1 GTPase-activating protein
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22614916
NCBI chr 4:137,391,549...137,457,172
Ensembl chr 4:137,392,037...137,457,172
G
H
RAP1GAP
RAP1 GTPase activating protein
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:22614916
NCBI chr 1:21,596,221...21,669,357
Ensembl chr 1:21,596,221...21,669,357
G
N
Rara
retinoic acid receptor alpha
ISO
OMIM
NCBI chrNW_004624795:2,935,432...2,975,226
Ensembl chrNW_004624795:2,934,731...2,967,232
G
G
RARA
retinoic acid receptor alpha
ISO
OMIM
NCBI chr16:65,817,849...65,866,862
Ensembl chr16:65,817,757...65,866,878
G
P
RARA
retinoic acid receptor alpha
ISO
OMIM
NCBI chr12:22,047,449...22,085,759
Ensembl chr12:22,047,443...22,085,673
G
S
Rara
retinoic acid receptor alpha
ISO
OMIM
NCBI chrNW_004936490:15,376,217...15,420,638
Ensembl chrNW_004936490:15,376,205...15,421,611
G
D
RARA
retinoic acid receptor alpha
ISO
OMIM
NCBI chr 9:22,254,803...22,298,614
Ensembl chr 9:22,254,806...22,289,459
G
B
RARA
retinoic acid receptor alpha
ISO
OMIM
NCBI chr17:16,932,485...16,980,958
G
C
Rara
retinoic acid receptor alpha
ISO
OMIM
NCBI chrNW_004955451:14,876,663...14,917,134
Ensembl chrNW_004955451:14,897,726...14,917,134
G
R
Rara
retinoic acid receptor, alpha
ISO
CTD Direct Evidence: marker/mechanism
CTD OMIM RGD
PMID:8616088 PMID:10742073 PMID:14508522 PMID:14706140 PMID:16239915 PMID:16788101 PMID:16835227 PMID:16891316 PMID:16935935 PMID:17294898 PMID:17649720 PMID:17712046 PMID:19029980 PMID:19035177 PMID:19884644 PMID:19887701 PMID:21613260 PMID:22213200 PMID:23208507 PMID:25583766 PMID:26285909 PMID:26728337 PMID:28314734 PMID:32882258 PMID:32929351 PMID:15659732 More...
RGD:1600902
NCBI chr10:84,379,780...84,424,371
Ensembl chr10:83,893,384...83,928,142
G
M
Rara
retinoic acid receptor, alpha
ISO
CTD Direct Evidence: marker/mechanism
CTD OMIM RGD
PMID:8616088 PMID:10742073 PMID:14508522 PMID:14706140 PMID:16239915 PMID:16788101 PMID:16835227 PMID:16891316 PMID:16935935 PMID:17294898 PMID:17649720 PMID:17712046 PMID:19029980 PMID:19035177 PMID:19884644 PMID:19887701 PMID:21613260 PMID:22213200 PMID:23208507 PMID:25583766 PMID:26285909 PMID:26728337 PMID:28314734 PMID:32882258 PMID:32929351 PMID:15659732 More...
RGD:1600902
NCBI chr11:98,818,626...98,865,768
Ensembl chr11:98,818,644...98,865,768
G
H
RARA
retinoic acid receptor alpha
TAS EXP IAGP
DNA:translocation:fusion_protein CTD Direct Evidence: marker/mechanism
CTD OMIM RGD
PMID:8616088 PMID:10742073 PMID:14508522 PMID:14706140 PMID:16239915 PMID:16788101 PMID:16835227 PMID:16891316 PMID:16935935 PMID:17294898 PMID:17649720 PMID:17712046 PMID:19029980 PMID:19035177 PMID:19884644 PMID:19887701 PMID:21613260 PMID:22213200 PMID:23208507 PMID:25583766 PMID:26285909 PMID:26728337 PMID:28314734 PMID:32882258 PMID:32929351 PMID:15659732 More...
RGD:1600902
NCBI chr17:40,309,180...40,357,643
Ensembl chr17:40,309,180...40,357,643
G
N
Retn
resistin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:32929351
NCBI chrNW_004624828:735,562...737,166
Ensembl chrNW_004624828:735,503...737,166
G
G
RETN
resistin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:32929351
NCBI chr 6:7,154,771...7,156,459
Ensembl chr 6:7,155,337...7,156,505
G
P
RETN
resistin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:32929351
NCBI chr 2:71,484,164...71,485,577
Ensembl chr 2:71,484,169...71,485,616
G
S
Retn
resistin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:32929351
NCBI chrNW_004936588:4,705,295...4,706,653
Ensembl chrNW_004936588:4,705,119...4,706,656
G
D
RETN
resistin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:32929351
NCBI chr20:52,434,148...52,435,627
Ensembl chr20:52,434,271...52,435,624
G
B
RETN
resistin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:32929351
NCBI chr19:6,958,536...6,960,032
Ensembl chr19:7,812,942...7,814,909
G
C
Retn
resistin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:32929351
NCBI chrNW_004955563:1,607,814...1,609,273
Ensembl chrNW_004955563:1,607,814...1,609,273
G
R
Retn
resistin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:32929351
NCBI chr12:6,508,653...6,511,115
Ensembl chr12:1,710,881...1,712,620
G
M
Retn
resistin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:32929351
NCBI chr 8:3,705,770...3,709,818
Ensembl chr 8:3,705,770...3,710,110
G
H
RETN
resistin
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:32929351
NCBI chr19:7,669,049...7,670,455
Ensembl chr19:7,669,049...7,670,455
G
N
Rock1
Rho associated coiled-coil containing protein kinase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:32417439
NCBI chrNW_004624770:10,592,304...10,731,640
G
G
ROCK1
Rho associated coiled-coil containing protein kinase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:32417439
NCBI chr18:59,384,822...59,538,780
Ensembl chr18:59,384,944...59,540,070
G
P
ROCK1
Rho associated coiled-coil containing protein kinase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:32417439
NCBI chr 6:106,163,899...106,314,998
Ensembl chr 6:106,163,989...106,314,944
G
S
Rock1
Rho associated coiled-coil containing protein kinase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:32417439
NCBI chrNW_004936550:730,462...874,601
Ensembl chrNW_004936550:733,239...874,601
G
D
ROCK1
Rho associated coiled-coil containing protein kinase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:32417439
NCBI chr 7:66,862,614...67,001,538
Ensembl chr 7:66,862,608...67,142,853
G
B
ROCK1
Rho associated coiled-coil containing protein kinase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:32417439
NCBI chr18:14,192,293...14,352,357
Ensembl chr18:17,833,047...17,990,086
G
C
Rock1
Rho associated coiled-coil containing protein kinase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:32417439
NCBI chrNW_004955402:9,752,101...9,864,317
Ensembl chrNW_004955402:9,750,730...9,864,317
G
R
Rock1
Rho-associated coiled-coil containing protein kinase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:32417439
NCBI chr18:1,387,360...1,509,218
Ensembl chr18:1,115,905...1,235,571
G
M
Rock1
Rho-associated coiled-coil containing protein kinase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:32417439
NCBI chr18:10,064,401...10,182,225
Ensembl chr18:10,064,401...10,182,045
G
H
ROCK1
Rho associated coiled-coil containing protein kinase 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:32417439
NCBI chr18:20,946,906...21,111,813
Ensembl chr18:20,944,612...21,111,813
G
N
Slit2
slit guidance ligand 2
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:33120864
NCBI chrNW_004624755:11,470,810...11,819,800
Ensembl chrNW_004624755:11,472,377...11,819,266
G
G
SLIT2
slit guidance ligand 2
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:33120864
NCBI chr27:29,650,589...30,020,105
Ensembl chr27:29,650,337...29,803,612
G
P
SLIT2
slit guidance ligand 2
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:33120864
NCBI chr 8:14,758,426...15,149,515
Ensembl chr 8:14,758,335...15,148,133
G
S
Slit2
slit guidance ligand 2
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:33120864
NCBI chrNW_004936477:8,111,212...8,448,567
Ensembl chrNW_004936477:8,109,228...8,446,653
G
D
SLIT2
slit guidance ligand 2
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:33120864
NCBI chr 3:88,964,707...89,311,817
Ensembl chr 3:88,966,232...89,312,955
G
B
SLIT2
slit guidance ligand 2
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:33120864
NCBI chr 4:14,654,448...15,023,708
Ensembl chr 4:20,158,952...20,314,656
G
C
Slit2
slit guidance ligand 2
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:33120864
NCBI chrNW_004955480:3,982,977...4,314,160
Ensembl chrNW_004955480:3,984,586...4,313,908
G
R
Slit2
slit guidance ligand 2
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:33120864
NCBI chr14:66,829,661...67,168,517
Ensembl chr14:62,617,067...62,955,948
G
M
Slit2
slit guidance ligand 2
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:33120864
NCBI chr 5:48,138,633...48,465,077
Ensembl chr 5:48,140,480...48,465,075
G
H
SLIT2
slit guidance ligand 2
EXP
CTD Direct Evidence: therapeutic
CTD
PMID:33120864
NCBI chr 4:20,251,905...20,620,561
Ensembl chr 4:20,251,905...20,620,561
G
N
Smo
smoothened, frizzled class receptor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23867347
NCBI chrNW_004624783:7,012,385...7,039,302
Ensembl chrNW_004624783:7,011,899...7,039,921
G
G
SMO
smoothened, frizzled class receptor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23867347
NCBI chr21:97,788,955...97,814,549
Ensembl chr21:97,788,624...97,814,709
G
P
SMO
smoothened, frizzled class receptor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23867347
NCBI chr18:19,450,730...19,478,796
Ensembl chr18:19,450,743...19,478,898
G
S
Smo
smoothened, frizzled class receptor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23867347
NCBI chrNW_004936579:5,893,064...5,917,021
Ensembl chrNW_004936579:5,892,542...5,917,281
G
D
SMO
smoothened, frizzled class receptor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23867347
NCBI chr14:7,518,871...7,527,703
Ensembl chr14:7,518,856...7,528,033
G
B
SMO
smoothened, frizzled class receptor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23867347
NCBI chr 7:121,143,968...121,168,873
Ensembl chr 7:133,668,304...133,693,048
G
C
Smo
smoothened, frizzled class receptor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23867347
NCBI chrNW_004955479:9,963,377...9,991,670
Ensembl chrNW_004955479:9,964,170...9,993,165
G
R
Smo
smoothened, frizzled class receptor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23867347
NCBI chr 4:59,311,084...59,341,280
Ensembl chr 4:58,343,529...58,373,829
G
M
Smo
smoothened, frizzled class receptor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23867347
NCBI chr 6:29,735,480...29,761,359
Ensembl chr 6:29,735,502...29,761,364
G
H
SMO
smoothened, frizzled class receptor
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:23867347
NCBI chr 7:129,188,633...129,213,545
Ensembl chr 7:129,188,633...129,213,545
G
N
Tet2
tet methylcytosine dioxygenase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26285909
NCBI chrNW_004624830:3,446,331...3,543,450
Ensembl chrNW_004624830:3,446,141...3,519,084
G
G
TET2
tet methylcytosine dioxygenase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26285909
NCBI chr 7:53,193,824...53,326,813
Ensembl chr 7:53,193,941...53,326,942
G
P
TET2
tet methylcytosine dioxygenase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26285909
NCBI chr 8:116,413,253...116,546,976
Ensembl chr 8:116,415,267...116,545,299
G
S
Tet2
tet methylcytosine dioxygenase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26285909
NCBI chrNW_004936752:440,137...577,339
Ensembl chrNW_004936752:440,136...577,615
G
D
TET2
tet methylcytosine dioxygenase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26285909
NCBI chr32:26,021,745...26,145,109
Ensembl chr32:26,059,693...26,143,536
G
B
TET2
tet methylcytosine dioxygenase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26285909
NCBI chr 4:97,612,439...97,745,544
Ensembl chr 4:108,269,082...108,358,400
G
C
Tet2
tet methylcytosine dioxygenase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26285909
NCBI chrNW_004955496:3,885,684...3,963,056
Ensembl chrNW_004955496:3,885,035...3,926,106
G
R
Tet2
tet methylcytosine dioxygenase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26285909
NCBI chr 2:224,662,654...224,746,819
Ensembl chr 2:221,988,645...222,072,534
G
M
Tet2
tet methylcytosine dioxygenase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26285909
NCBI chr 3:133,169,438...133,250,882
Ensembl chr 3:133,169,440...133,250,900
G
H
TET2
tet methylcytosine dioxygenase 2
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:26285909
NCBI chr 4:105,145,875...105,279,803
Ensembl chr 4:105,145,875...105,279,816
G
N
Thbd
thrombomodulin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16206674
NCBI chrNW_004624741:22,880,481...22,883,962
G
G
THBD
thrombomodulin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16206674
NCBI chr 2:52,041,950...52,045,946
Ensembl chr 2:52,043,746...52,045,626
G
P
THBD
thrombomodulin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16206674
NCBI chr17:30,219,870...30,223,499
Ensembl chr17:30,217,303...30,224,099
G
S
Thbd
thrombomodulin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16206674
NCBI chrNW_004936620:2,563,900...2,568,117
G
D
THBD
thrombomodulin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16206674
NCBI chr24:599,773...601,649
Ensembl chr24:599,773...601,649
G
B
THBD
thrombomodulin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16206674
NCBI chr20:22,992,341...22,996,415
Ensembl chr20:23,345,917...23,347,812
G
C
Thbd
thrombomodulin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16206674
NCBI chrNW_004955415:30,222,830...30,226,406
G
R
Thbd
thrombomodulin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16206674
NCBI chr 3:156,316,526...156,320,178
Ensembl chr 3:135,862,835...135,867,193
G
M
Thbd
thrombomodulin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16206674
NCBI chr 2:148,246,391...148,250,108
Ensembl chr 2:148,246,386...148,250,108
G
H
THBD
thrombomodulin
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:16206674
NCBI chr20:23,045,633...23,049,672
Ensembl chr20:23,045,633...23,049,672
G
N
Tmem127
transmembrane protein 127
ISO
ClinVar Annotator: match by term: Acute promyelocytic leukemia
ClinVar
PMID:25741868 PMID:28492532 PMID:32575117
NCBI chrNW_004624749:2,333,472...2,344,652
Ensembl chrNW_004624749:2,333,472...2,344,674
G
G
TMEM127
transmembrane protein 127
ISO
ClinVar Annotator: match by term: Acute promyelocytic leukemia
ClinVar
PMID:25741868 PMID:28492532 PMID:32575117
NCBI chr14:671,259...685,217
Ensembl chr14:673,375...685,228
G
P
TMEM127
transmembrane protein 127
ISO
ClinVar Annotator: match by term: Acute promyelocytic leukemia
ClinVar
PMID:25741868 PMID:28492532 PMID:32575117
NCBI chr 3:46,966,858...47,017,659
Ensembl chr 3:46,966,892...46,978,810
G
S
Tmem127
transmembrane protein 127
ISO
ClinVar Annotator: match by term: Acute promyelocytic leukemia
ClinVar
PMID:25741868 PMID:28492532 PMID:32575117
NCBI chrNW_004936744:344,356...359,086
Ensembl chrNW_004936744:344,356...359,044
G
D
TMEM127
transmembrane protein 127
ISO
ClinVar Annotator: match by term: Acute promyelocytic leukemia
ClinVar
PMID:25741868 PMID:28492532 PMID:32575117
NCBI chr17:34,512,753...34,527,208
Ensembl chr17:34,512,792...34,523,692
G
B
TMEM127
transmembrane protein 127
ISO
ClinVar Annotator: match by term: Acute promyelocytic leukemia
ClinVar
PMID:25741868 PMID:28492532 PMID:32575117
NCBI chr2A:103,049,655...103,065,116
Ensembl chr2A:97,174,322...97,189,171
G
C
Tmem127
transmembrane protein 127
ISO
ClinVar Annotator: match by term: Acute promyelocytic leukemia
ClinVar
PMID:25741868 PMID:28492532 PMID:32575117
NCBI chrNW_004955470:3,809,835...3,822,442
Ensembl chrNW_004955470:3,808,455...3,822,497
G
R
Tmem127
transmembrane protein 127
ISO
ClinVar Annotator: match by term: Acute promyelocytic leukemia
ClinVar
PMID:25741868 PMID:28492532 PMID:32575117
NCBI chr 3:134,919,416...134,932,210
Ensembl chr 3:114,466,171...114,477,519
G
M
Tmem127
transmembrane protein 127
ISO
ClinVar Annotator: match by term: Acute promyelocytic leukemia
ClinVar
PMID:25741868 PMID:28492532 PMID:32575117
NCBI chr 2:127,089,868...127,103,028
Ensembl chr 2:127,089,828...127,103,027
G
H
TMEM127
transmembrane protein 127
IAGP
ClinVar Annotator: match by term: Acute promyelocytic leukemia
ClinVar
PMID:25741868 PMID:28492532 PMID:32575117
NCBI chr 2:96,248,514...96,265,997
Ensembl chr 2:96,248,500...96,266,047
G
G
TOP2A
DNA topoisomerase II alpha
ISO
ClinVar Annotator: match by term: Dna topoisomerase II, resistance to inhibition of, by amsacrine
ClinVar
PMID:1651812
NCBI chr16:65,761,391...65,792,041
Ensembl chr16:65,761,416...65,792,701
G
P
TOP2A
DNA topoisomerase II alpha
ISO
ClinVar Annotator: match by term: Dna topoisomerase II, resistance to inhibition of, by amsacrine
ClinVar
PMID:1651812
NCBI chr12:22,001,300...22,028,452
Ensembl chr12:22,001,282...22,028,450
G
S
Top2a
DNA topoisomerase II alpha
ISO
ClinVar Annotator: match by term: Dna topoisomerase II, resistance to inhibition of, by amsacrine
ClinVar
PMID:1651812
NCBI chrNW_004936490:15,441,463...15,465,692
Ensembl chrNW_004936490:15,441,575...15,466,978
G
D
TOP2A
DNA topoisomerase II alpha
ISO
ClinVar Annotator: match by term: Dna topoisomerase II, resistance to inhibition of, by amsacrine
ClinVar
PMID:1651812
NCBI chr 9:22,207,501...22,237,497
Ensembl chr 9:22,207,638...22,237,496
G
B
TOP2A
DNA topoisomerase II alpha
ISO
ClinVar Annotator: match by term: Dna topoisomerase II, resistance to inhibition of, by amsacrine
ClinVar
PMID:1651812
NCBI chr17:16,872,169...16,901,605
Ensembl chr17:17,097,778...17,126,207
G
C
Top2a
DNA topoisomerase II alpha
ISO
ClinVar Annotator: match by term: Dna topoisomerase II, resistance to inhibition of, by amsacrine
ClinVar
PMID:1651812
NCBI chrNW_004955451:14,928,273...14,964,855
Ensembl chrNW_004955451:14,929,136...14,964,723
G
R
Top2a
DNA topoisomerase II alpha
ISO
ClinVar Annotator: match by term: Dna topoisomerase II, resistance to inhibition of, by amsacrine
ClinVar
PMID:1651812
NCBI chr10:84,441,954...84,473,093
Ensembl chr10:83,945,735...83,976,874
G
M
Top2a
topoisomerase (DNA) II alpha
ISO
ClinVar Annotator: match by term: Dna topoisomerase II, resistance to inhibition of, by amsacrine
ClinVar
PMID:1651812
NCBI chr11:98,883,773...98,915,037
Ensembl chr11:98,883,769...98,915,015
G
H
TOP2A
DNA topoisomerase II alpha
IAGP
ClinVar Annotator: match by term: Dna topoisomerase II, resistance to inhibition of, by amsacrine
ClinVar
PMID:1651812
NCBI chr17:40,388,525...40,417,896
Ensembl chr17:40,388,525...40,417,896
G
N
Trib3
tribbles pseudokinase 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:32929351
NCBI chrNW_004624741:1,486,223...1,494,005
Ensembl chrNW_004624741:1,484,863...1,494,829
G
G
TRIB3
tribbles pseudokinase 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:32929351
NCBI chr 2:35,512,911...35,530,856
Ensembl chr 2:35,512,861...35,530,966
G
P
TRIB3
tribbles pseudokinase 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:32929351
NCBI chr17:34,808,273...34,819,592
Ensembl chr17:34,807,582...34,816,451
G
S
Trib3
tribbles pseudokinase 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:32929351
NCBI chrNW_004936485:18,077,850...18,082,817
Ensembl chrNW_004936485:18,077,850...18,083,553
G
D
TRIB3
tribbles pseudokinase 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:32929351
NCBI chr24:20,450,281...20,461,141
Ensembl chr24:20,451,001...20,457,510
G
B
TRIB3
tribbles pseudokinase 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:32929351
NCBI chr20:583,267...605,416
Ensembl chr20:359,879...375,486
G
C
Trib3
tribbles pseudokinase 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:32929351
NCBI chrNW_004955597:259,209...265,896
Ensembl chrNW_004955597:260,790...265,326
G
R
Trib3
tribbles pseudokinase 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:32929351
NCBI chr 3:161,269,939...161,275,533
Ensembl chr 3:140,809,043...140,814,497
G
M
Trib3
tribbles pseudokinase 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:32929351
NCBI chr 2:152,179,345...152,185,980
Ensembl chr 2:152,179,342...152,185,952
G
H
TRIB3
tribbles pseudokinase 3
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:32929351
NCBI chr20:380,760...397,559
Ensembl chr20:362,835...397,559
G
N
Wt1
WT1 transcription factor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26285909
NCBI chrNW_004624766:20,899,546...20,937,084
Ensembl chrNW_004624766:20,900,676...20,937,202
G
G
WT1
WT1 transcription factor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26285909
NCBI chr 1:32,750,300...32,801,832
G
P
WT1
WT1 transcription factor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26285909
NCBI chr 2:28,411,467...28,456,007
Ensembl chr 2:28,411,803...28,455,997
G
S
Wt1
WT1 transcription factor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26285909
NCBI chrNW_004936533:5,411,949...5,459,693
Ensembl chrNW_004936533:5,411,848...5,459,693
G
D
WT1
WT1 transcription factor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26285909
NCBI chr18:35,099,660...35,148,767
Ensembl chr18:35,103,934...35,148,000
G
B
WT1
WT1 transcription factor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26285909
NCBI chr11:32,349,807...32,398,494
Ensembl chr11:32,238,720...32,287,249
G
C
Wt1
WT1 transcription factor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26285909
NCBI chrNW_004955476:10,464,688...10,504,473
Ensembl chrNW_004955476:10,464,616...10,504,473
G
R
Wt1
WT1 transcription factor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26285909
NCBI chr 3:112,019,721...112,068,454
Ensembl chr 3:91,567,001...91,613,643
G
M
Wt1
WT1 transcription factor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26285909
NCBI chr 2:104,956,874...105,003,959
Ensembl chr 2:104,956,874...105,003,961
G
H
WT1
WT1 transcription factor
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:26285909
NCBI chr11:32,387,775...32,435,539
Ensembl chr11:32,387,775...32,435,564
G
N
Zbtb16
zinc finger and BTB domain containing 16
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:8387545 PMID:23208507
RGD:1599922
NCBI chrNW_004624784:9,545,529...9,726,960
Ensembl chrNW_004624784:9,546,509...9,726,960
G
G
ZBTB16
zinc finger and BTB domain containing 16
ISO
CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:8387545 PMID:23208507
RGD:1599922
NCBI chr 1:105,446,067...105,648,771
Ensembl chr 1:105,449,994...105,643,344
G
P
ZBTB16
zinc finger and BTB domain containing 16
ISO
CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:8387545 PMID:23208507
RGD:1599922
NCBI chr 9:41,639,536...41,839,254
Ensembl chr 9:41,639,701...41,836,742
G
S
Zbtb16
zinc finger and BTB domain containing 16
ISO
CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:8387545 PMID:23208507
RGD:1599922
NCBI chrNW_004936612:389,877...570,595
Ensembl chrNW_004936612:395,177...570,595
G
D
ZBTB16
zinc finger and BTB domain containing 16
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:8387545 PMID:23208507
RGD:1599922
NCBI chr 5:19,082,594...19,284,360
Ensembl chr 5:19,087,154...19,267,628
G
B
ZBTB16
zinc finger and BTB domain containing 16
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:8387545 PMID:23208507
RGD:1599922
NCBI chr11:108,938,414...109,133,819
Ensembl chr11:112,780,380...112,977,164
G
C
Zbtb16
zinc finger and BTB domain containing 16
ISO
CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:8387545 PMID:23208507
RGD:1599922
NCBI chrNW_004955412:15,668,332...15,845,384
Ensembl chrNW_004955412:15,668,332...15,845,372
G
R
Zbtb16
zinc finger and BTB domain containing 16
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:23208507 PMID:8387545
RGD:1599922
NCBI chr 8:57,885,886...58,073,507
Ensembl chr 8:48,994,566...49,177,011
G
M
Zbtb16
zinc finger and BTB domain containing 16
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23208507
NCBI chr 9:48,563,097...48,747,525
Ensembl chr 9:48,565,597...48,747,522
G
H
ZBTB16
zinc finger and BTB domain containing 16
IAGP EXP
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:23208507 PMID:8387545
RGD:1599922
NCBI chr11:114,059,711...114,256,770
Ensembl chr11:114,059,041...114,256,765
Symbol
Object Name
Qualifiers
Evidence
Notes
Source
PubMed Reference(s)
RGD Reference(s)
Position
G
N
Zbtb16
zinc finger and BTB domain containing 16
ISO
ClinVar Annotator: match by term: ZBTB16-related condition
ClinVar
PMID:28492532
NCBI chrNW_004624784:9,545,529...9,726,960
Ensembl chrNW_004624784:9,546,509...9,726,960
G
G
ZBTB16
zinc finger and BTB domain containing 16
ISO
ClinVar Annotator: match by term: ZBTB16-related condition
ClinVar
PMID:28492532
NCBI chr 1:105,446,067...105,648,771
Ensembl chr 1:105,449,994...105,643,344
G
P
ZBTB16
zinc finger and BTB domain containing 16
ISO
ClinVar Annotator: match by term: ZBTB16-related condition
ClinVar
PMID:28492532
NCBI chr 9:41,639,536...41,839,254
Ensembl chr 9:41,639,701...41,836,742
G
S
Zbtb16
zinc finger and BTB domain containing 16
ISO
ClinVar Annotator: match by term: ZBTB16-related condition
ClinVar
PMID:28492532
NCBI chrNW_004936612:389,877...570,595
Ensembl chrNW_004936612:395,177...570,595
G
D
ZBTB16
zinc finger and BTB domain containing 16
ISO
ClinVar Annotator: match by term: ZBTB16-related condition
ClinVar
PMID:28492532
NCBI chr 5:19,082,594...19,284,360
Ensembl chr 5:19,087,154...19,267,628
G
B
ZBTB16
zinc finger and BTB domain containing 16
ISO
ClinVar Annotator: match by term: ZBTB16-related condition
ClinVar
PMID:28492532
NCBI chr11:108,938,414...109,133,819
Ensembl chr11:112,780,380...112,977,164
G
C
Zbtb16
zinc finger and BTB domain containing 16
ISO
ClinVar Annotator: match by term: ZBTB16-related condition
ClinVar
PMID:28492532
NCBI chrNW_004955412:15,668,332...15,845,384
Ensembl chrNW_004955412:15,668,332...15,845,372
G
R
Zbtb16
zinc finger and BTB domain containing 16
ISO
ClinVar Annotator: match by term: ZBTB16-related condition
ClinVar
PMID:28492532
NCBI chr 8:57,885,886...58,073,507
Ensembl chr 8:48,994,566...49,177,011
G
M
Zbtb16
zinc finger and BTB domain containing 16
ISO
ClinVar Annotator: match by term: ZBTB16-related condition
ClinVar
PMID:28492532
NCBI chr 9:48,563,097...48,747,525
Ensembl chr 9:48,565,597...48,747,522
G
H
ZBTB16
zinc finger and BTB domain containing 16
IAGP
ClinVar Annotator: match by term: ZBTB16-related condition
ClinVar
PMID:28492532
NCBI chr11:114,059,711...114,256,770
Ensembl chr11:114,059,041...114,256,765
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all